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2 Summary
Flaviviruses, comprising important human pathogens such as dengue virus, Japa-
nese encephalitis virus, West Nile virus, yellow fever virus and tick-borne encephalitis
virus (TBEV), enter cells by receptor-mediated endocytosis and low-pH-induced fu-
sion from within the endosome. Fusion of the viral with the endosomal membrane
is mediated by the major envelope protein E, a class II viral fusion protein, which is
organized on the virus surface as metastable dimers forming an icosahedral shell. In
the course of membrane fusion, the E protein homodimers are irreversibly converted
to more stable homotrimers, thereby releasing energy for the fusion process. The
external part of E, which is composed of three distinct domains (DI, DII, DIII), is
connected to the double transmembrane anchor by a membrane-proximal region, the
so-called stem. The current fusion models hypothesize that the stem zippers along
the core of the trimer and interacts with the trimeric ectodomain in the postfusion
conformation. In this work, we wanted to generate direct experimental evidence for
the importance of stem-trimer core interactions and investigate the role of the stem
region in ﬂavivirus membrane fusion.
In the ﬁrst part of the thesis, we addressed this question by mutagenesis of recom-
binant subviral particles (RSPs) of TBEV. We targeted highly conserved residues in
the stem and at possible stem interaction sites in the E protein DII and assessed the
eﬀect of these mutations on diﬀerent stages of membrane fusion. By this approach,
we could demonstrate that the stem region is crucial for late stages of the fusion
process and contributes to the postfusion trimer stability. Moreover, the substitu-
tion of the DII residue L223 by an isoleucine, drastically aﬀected the thermostability
of the E protein trimer and RSP fusion activity. This negative eﬀect was partially
compensated by additionally replacing the stem residue F403 to an isoleucine. The
double mutant L223I-F403I exhibited enhanced trimer stability and fusion activity
compared to the single mutant L223I, indicating a speciﬁc interaction site between
the stem and the trimer core, which is important for the stability of the E protein
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postfusion conformation and particle fusion.
In the second part of this thesis, we wanted to supplement the data, obtained with
the RSP system, by investigating the eﬀect of these mutations on infectivity in the
infectious virus system. Both mutations (L223I and L223I-F403I) were introduced
into the infectious clone of TBEV strain Neudoerﬂ. We discovered that both mutant
viruses (L223I and L223I-F403I) were still infectious, although with a reduction in
their speciﬁc infectivity in comparison to wild-type virus. Apparently, fusion data
obtained with mutated RSPs cannot be readily extended to the infectious system
and further studies are needed to clarify this point. A possible explanation for this
discrepancy could be the diﬀerence in particle geometry. Whereas on RSPs 30 E
protein dimers are organized in a T=1 symmetry, on virions 90 E protein dimers are
more densely packed in a herringbone-like lattice. This special arrangement might
provide cooperative eﬀects on virions, resulting in a less dramatic eﬀect of introduced
mutations on viral fusion. In addition, we could show that mutations, which did not
result in particle secretion in the RSP system, allowed the generation of infectious
virions.
In this work, we were able to reveal mechanistic details on the role of the stem
region in ﬂavivirus fusion, especially through the use of RSPs. We identiﬁed an
intramolecular interaction site, which clearly stabilizes the postfusion trimer and
facilitates membrane fusion. The observed discrepancies between RSP and infectious
virus system will be investigated in future studies.
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3 Zusammenfassung
Zum Genus der Flaviviren za¨hlen eine Reihe von humanpathogenen Krankheitser-
regern wie Gelbﬁebervirus, Dengue-Virus, West Nil Virus, Japanische Enzephalitis
Virus und Fru¨hsommer-Meningoenzephalitis (FSME) Virus. Flaviviren gelangen
durch Rezeptor-vermittelte Endocytose in die Zelle und der saure pH im Endosom
induziert die Fusion von viraler und endosomaler Membran. Dieser Fusionsprozess
wird von dem viralen Hu¨llprotein E, einem Klasse II Fusionsprotein vermittelt, das
eine Dimer-Trimer-Umwandlung durchla¨uft und dabei Energie fu¨r die Fusion zur
Verfu¨gung stellt. Der externe Teil des E Proteins, der aus 3 Doma¨nen (DI, DII,
DIII) zusammengesetzt ist, wird durch eine sogenannte Stamm-Region mit einem
Doppel-Transmembrananker verbunden. In derzeitigen Modellen wird vermutet,
dass speziﬁsche Interaktionen des Stammes mit der DII des Trimers die treibende
Kraft fu¨r die spa¨ten Phasen der Fusion (also das Verschmelzen der beiden Lipid
Bilayer) darstellen. Das Hauptziel dieser Arbeit bestand darin, einen eindeutigen
Nachweis fu¨r die Bedeutung der Stamm-Trimer-Interaktion zu ﬁnden und die Rolle
der Stamm-Region in der Membranfusion von Flaviviren zu untersuchen.
Im ersten Teil dieser Arbeit wurde diese Fragestellung durch Mutagenese von
Rekombinanten Subviralen Partikeln (RSP) des FSME Virus behandelt. Wir mu-
tierten konservierte Reste im Stamm und in mo¨glichen Interaktionsregionen und
analysierten den Einﬂuss der Mutationen auf verschiedene Schritte des Fusionspro-
zesses. Am Beispiel mehrerer Stamm-Mutanten konnten wir nachweisen, dass die
Stamm-Region fu¨r die spa¨ten Stadien der Fusion bedeutend ist. Desweiteren war es
uns mo¨glich, eine speziﬁsche Interaktion zwischen Stamm und Trimer-Ektodoma¨ne
zu identiﬁzieren. Die Mutation (L223I) in DII beeintra¨chtigte stark die Thermosta-
bilita¨t des Trimers und zugleich die Fusogenita¨t der RSP-Mutante. Dieser negative
Eﬀekt konnte durch eine zusa¨tzliche Mutation im Stamm zumindest teilweise kom-
pensiert werden. Im Vergleich zur Einzelmutante wies die Doppelmutante (L223I-
F403I) verbesserte Trimerstabilita¨t und Fusionsaktivita¨t auf.
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Im zweiten Teil dieser Arbeit analysierten wir diese Interaktion im infektio¨sen Sys-
tem und fu¨hrten die im RSP-System charakterisierten Mutationen in den infektio¨sen
FSME Virus-Klon ein. U¨berraschenderweise waren beide Virusmutanten (L223I und
L223I-F403I) infektio¨s, obgleich sie eine Reduktion in ihrer speziﬁschen Infektiosita¨t
im Vergleich zum Wildtyp aufwiesen. Oﬀensichtlich ko¨nnen Fusionsaktivita¨ten von
RSP-Mutanten nicht direkt auf das infektio¨se System u¨bertragen werden, was in
zuku¨nftigen Studien genauer untersucht werden muss. Eine mo¨gliche Erkla¨rung fu¨r
diese Diskrepanz ko¨nnte die unterschiedliche Geometrie von RSP und Virionen sein.
Wa¨hrend an der Oberﬂa¨che von RSP 30 E Proteindimere in einer T=1 Symmetrie or-
ganisiert sind, sind an der Oberﬂa¨che von Virionen 90 E Proteindimere dicht in einer
Fischgra¨ten-a¨hnlichen Anordnung gepackt. Diese spezielle E Proteinanordnung auf
Virionen ko¨nnte zusa¨tzliche kooperative Eﬀekte ermo¨glichen, welche Auswirkungen
von Mutationen auf die Virusfusion abschwa¨chen. Daru¨berhinaus stellten wir fest,
dass Mutationen, welche die Sekretion von Partikeln im RSP System verhindern, die
Produktion von infektio¨sen Viren erlauben.
Wir konnten mit dieser Arbeit mechanistische Details u¨ber die Rolle der Stamm-
Region in der Membranfusion von Flaviviren aufdecken. Wir identiﬁzierten eine
speziﬁsche intramolekulare Interaktion zwischen Stamm und DII, welche fu¨r die
Stabilita¨t der Postfusionsstruktur von großer Bedeutung ist und Membranfusion
begu¨nstigt. Das unterschiedliche Ausmaß der Auswirkungen von Mutationen auf
RSP und Viren muss in weiterfu¨hrenden Studien genauer untersucht werden.
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4.1 Flaviviruses
The family Flaviviridae comprises three genera: Hepacivirus, Pestivirus and Fla-
vivirus (18). All members of this family have similar characteristics in morpho-
logy, genome composition and replication. The largest genus Flavivirus includes
more than 70 viruses which are mostly transmitted by mosquitoes or ticks (Figure
4.1). For some ﬂaviviruses the vector is unknown (42). The most important human
pathogens are dengue virus (DENV), Japanese encephalitis virus (JEV), West Nile
virus (WNV), yellow fever virus (YFV) and tick-borne encephalitis virus (TBEV)
which can cause severe diseases inducing symptoms that range from mild fever and
malaise to fatal encephalitis (42).
Figure 4.1: Flavivirus classiﬁcation. Relationships between ﬂaviviruses according to the amino
acid sequence of the envelope protein. Serocomplexes are shown in four colors: red, dengue virus
serocomplex; green, Japanese encephalitis serocomplex; orange, yellow fever virus serocomplex;
blue, tick-borne encephalitis virus serocomplex. The corresponding transmission vector is shown
on the right side. SLE, Saint Louis encephalitis; MVE, Murray Valley encephalitis; POW, Powassan
(adapted from (67)).
TBEV is further subdivided into the three subtypes: Far Eastern, Siberian and
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European subtype. Sequence analysis demonstrated a close relationship between
these subtypes (15, 18). TBEV is usually transmitted by tick bites, but human in-
fections can also occur through the consumption of unpasteurized milk from infected
goat, sheep or cow (27, 31). In Europe, two vaccines are licensed, both containing
highly puriﬁed, formalin-inactivated European TBEV strains (8).
4.1.1 Flavivirus particles
Figure 4.2: Schematic illustration of ﬂavivirus particles and genome organization. (A) Immature
virions have two membrane proteins (prM and E), which form heterodimers (left). The prM
protein is cleaved during maturation, resulting in the rearrangement of E into homodimers, present
on mature virions (right). The surface proteins are integrated in a host-derived lipid bilayer, which
surrounds the nucleocapsid composed of protein C and the viral genome. (B) The positive-sense
RNA genome consists of one open reading frame (ORF) and encodes the structural proteins C,
prM and E, followed by non-structural proteins (NSP). The ORF is ﬂanked by non-coding regions
(NCR) (modiﬁed from (66)).
Flaviviruses are enveloped viruses with a dense, icosahedral outer glycoprotein
shell and a diameter of approximately 50 nm. Virions are composed of a host-
derived, polygonal lipid bilayer into which the viral glycoproteins E and prM/M
are integrated. In the interior, a single positive-sense RNA genome of approximately
11kb in length is packaged by capsid proteins, forming the viral nucleocapsid (Figure
14
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4.2) (42).
The viral genome has one open reading frame and encodes a single polyprotein
(Figure 4.2 B). In the host cell the polyprotein is processed into 3 structural (C,
prM, E) and 7 non-structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) proteins,
which are important for viral replication. The protein C (12 – 14 kDa) is essential in
particle assembly and encapsidates the viral genome (42). Protein prM, a precursor
form of M, is present on the surface of immature particles (Figure 4.2 A). Upon
maturation the pr peptide is cleaved oﬀ, while the M protein remains anchored to
the viral membrane. During polyprotein synthesis, prM functions as a chaperone for
E protein folding and assembly (48).
4.1.2 Flavivirus life cycle
Flaviviruses enter the host cell via receptor-mediated endocytosis. After virus
attachment to the cell and particle endocytosis, the acidic pH in the endosome trig-
gers fusion between the viral and the endosomal membrane (48). The nucleocapsid
is released into the cytoplasm where it is subsequently disassembled, thus enabling
translation of the positive-stranded RNA (Figure 4.3). The viral genome is the only
viral mRNA and codes for a single polyprotein, which is translocated and anchored
to the membrane of the endoplasmic reticulum (ER) by several stop-transfer and
signal sequences which control the compartmentalization of the individual proteins.
The subsequent cleavages by cellular and viral proteases regulate the polyprotein
processing and production of the individual structural and non-structural proteins
(Figure 4.4) (48, 66).
Viral particles assembled in the lumen of the ER are immature. They are com-
posed of the nucleocapsid, surrounded by an ER-derived lipid bilayer, carrying the
glycoproteins prM and E (Figure 4.2 A) (48). These particles are not infectious.
Maturation occurs in the trans-Golgi network (TGN) at low pH, where the cellular
protease furin cleaves the precursor protein prM (63). Upon cleavage the prM/E
heterodimer rearranges to form E homodimers. The N-terminal pr peptide remains
attached to the M protein until the particle is released from the cell by exocytosis
15
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Figure 4.3: Flavivirus life cycle. Flaviviruses enter the cell via receptor-mediated endocytosis.
Fusion between viral and endosomal membrane is triggered by acidic pH in the endosome and
results in the release of the viral genome into the cytoplasm, where viral translation and replication
takes place. Polyprotein processing and virus assembly happens in the ER, from which immature
particles are released. The maturation cleavage of the precursor protein prM occurs in the TGN,
by the cellular protease furin. Viral particles are released from the host cell by exocytosis (modiﬁed
from (48)).
(Figure 4.3), thus preventing the premature fusion of the particle during exocytosis.
Release of the pr peptide is triggered by a change to neutral pH, present in the
extracellular environment (76).
A characteristic feature of ﬂavivirus infection is the production of non-infectious
subviral particles (SVP) in addition to the production and release of infectious viri-
ons. SVPs are capsidless, enveloped particles that contain the two viral membrane-
associated proteins M and E (61, 70).
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Figure 4.4: Topology of ﬂavivirus structural and non-structural proteins in the ER membrane.
Cleavage sites are indicated by arrows. Color code: capsid protein, red; prM, blue; E protein, cyan;
NS1, brown; NS2A, magenta; NS2B, green; NS3, dark brown; NS4A, orange; NS4B, purple; NS5,
light pink (adapted from (71)).
4.2 Entry of enveloped viruses
Enveloped viruses enter cells by fusion of the viral membrane with a cellular mem-
brane after virus attachment to the cell. Fusion can occur either directly at the
plasma membrane or after endocytosis, with membranes of intracellular compart-
ments, e.g. endosomes. The process is mediated by specialized fusion proteins,
which are present on the viral surface. In many cases, these proteins have additional
functions, such as receptor binding. This interaction, along with changes in physico-
chemical parameters, such as pH, trigger large conformational rearrangements of the
fusion proteins, which provide the main energy for membrane fusion (23, 74).
Flaviviruses bind to the host cell surface by interaction of the viral glycopro-
tein E with cellular receptors. Flavivirus particles can interact with diverse surface
molecules on diﬀerent cell types, but only a few receptors have been identiﬁed. Gly-
cosaminoglycans have been shown to function as low-aﬃnity receptors (38). More
speciﬁc interactions are supposed to take place between cellular surface proteins and
the protruding domain III of protein E (Figure 4.7) (29). The carbohydrate side
chains of E have been shown to interact with the lectin receptor DC-SIGN in DENV
and WNV attachment to immature dendritic cells (66). Prior to fusion, the attached
virion is internalized by receptor-mediated endocytosis and transported by clathrin-
coated pits to a pre-lysosomal compartment (11, 42). In the endosome, the acidic
17
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pH induces the structural rearrangements of the fusion protein E, which cause the
merging of the two opposed bilayers and allow the release of the viral genome into
the host cytoplasm (42).
4.2.1 Structural classes of viral fusion proteins and mechanisms of fusion
Three diﬀerent structural classes of viral membrane fusion proteins have been
described (23, 74). Fusion proteins found in retro-, ﬁlo-, corona-, paramyxo- and
orthomyxoviruses have been typed as class I fusion proteins (57). Based on their
structure and function, the fusion proteins of alpha- and ﬂaviviruses represent the
second class (33). Fusion proteins combining characteristics of both classes have
been identiﬁed in rhabdo-, baculo- and herpesviruses. They have been classiﬁed as
class III fusion proteins (7).
4.2.1.1 Class I viral fusion proteins
Class I viral fusion proteins are present on the surface of viral particles as ho-
motrimers with an α-helical coiled-coil structure in the centre. In many cases, these
proteins are synthesized as precursor proteins, which require a proteolytic maturation
cleavage, generating a carboxy-terminal fragment. This fragment ﬁnally represents
the actual fusion-active subunit with a hydrophobic, glycine-rich “fusion peptide”
at its N-terminus (23). The rod-like structure resembles the architecture of cellular
SNARE fusion proteins (62).
The fusion protein hemagglutinin (HA) of inﬂuenza virus serves as the prototype
of a class I fusion protein (57).
Pre-and postfusion conformation of inﬂuenza HA
HA was the ﬁrst structure of a viral fusion protein which was solved in its native
and in part, in its postfusion conformation (74). HA is synthesized as a trimeric HA0
precursor protein, C-terminally anchored to the viral membrane. HA0 is proteoly-
tically processed into the two polypeptide chains HA1 (receptor binding) and HA2,
18
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Figure 4.5: Structures of inﬂuenza HA. Each monomeric subunit is displayed in a diﬀerent color.
The monomers are C-terminally anchored in the viral membrane. (A) Prefusion structure of in-
ﬂuenza HA. The red asterisk indicates the shielded fusion peptide. (B) Proposed extended inter-
mediate of inﬂuenza HA. HA1 domains have dissociated from each other and the fusion peptide
is translocated towards the target membrane for interaction. (C) Postfusion conformation of in-
ﬂuenza HA. The extended intermediate of HA2 has collapsed and the typical hairpin conformation
is formed (adapted from) (23)).
which mediates fusion. A disulphide bridge covalently associates HA1 and HA2 (60).
The proteolytic cleavage of HA0 does not induce major conformational changes (23).
The native metastable HA is a homotrimer, composed of two structural regions
(Figure 4.5 A): a ﬁbrous region combining structures of HA1 and HA2 and a glo-
bular (HA1) region, which is positioned on the top of the elongated segment. The
centre of the trimer is built by a triple-stranded, α-helical coiled-coil (HA2). The
backbone of each monomer consists of two antiparallel helices connected by a bent
loop. On top of the central coiled-coil the receptor-binding domain HA1, built up
by an eight-stranded-β-sheet-structure, stabilizes the HA2 forming a clip around the
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centre (75). In the native prefusion conformation the hydrophobic fusion peptide at
the N-terminus of HA2 is buried in the trimer interface (28). Inﬂuenza virus enters
the cell via receptor-mediated endocytosis. The acidic pH in the endosome induces
a conformational change in the HA protein. Two sequential structural alterations
are signiﬁcant for the refolding process of the protein, facilitated by the dissocia-
tion of the HA1 domains (Figure 4.5 B) (23). First, a non-structured loop converts
into a helical segment, bringing up the previously buried fusion peptide for target
membrane interaction. Then, this segment turns back and zips up along the triple-
stranded coiled-coil core, resulting in the juxtaposition of the fusion peptide and the
transmembrane region in the fused membranes. This postfusion trimer resembles
the shape of a hairpin (ﬁgure 4.5 C) (57).
Proposed class I membrane fusion mechanism
Structural data are only available for the pre-and postfusion conformations of class
I fusion proteins. However, based on mutational, biochemical and biophysical stud-
ies general characteristics of a class I fusion pathway with intermediate structures
have been proposed (Figure 4.6) (23). Upon exposure to the low pH of the en-
dosomes, the HA1 subunits move away, allowing HA2 to undergo a conformational
change that drives the fusion reaction. On the native viral particle, HA2 is present
as a metastable trimer burying the fusion peptide. Low pH triggers the extension
of the central helix and exposure of the fusion peptide for target membrane inter-
action (48). Subsequently, the extended chain folds back, facilitating the bending
of the two membranes. A hemifusion intermediate in which just the outer leaﬂets
have merged is believed to lead over to the helical postfusion hairpin structure in
which the inserted fusion peptide and the transmembrane anchor are next to each
other (23, 48). The opening and dilation of the fusion pore allows the entry of the
nucleocapsid into the cell.
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Figure 4.6: Proposed class I fusion process. (A) Native, trimeric class I fusion protein with
the fusion peptide in red. (B,C) Upon exposure to the initial fusion trigger, the fusion protein
converts into an extended intermediate conformation and the fusion peptides interact with the
host membrane. (D) Conformational change in the fusion protein drive the bending of the viral
and the target membrane towards each other. (E) Hemifusion intermediate. (F) Postfusion,
hairpin conformation with the fusion peptides and the transmembrane anchors juxtaposed in the
same membrane (adapted from (48)).
4.2.1.2 Class II viral fusion proteins
The fusion machineries of alpha- and ﬂaviviruses consist of class II fusion pro-
teins. They convert from a metastable hetero- or homodimer into an energetically
favourable postfusion homotrimer and are mainly composed of beta-sheets (Figure
4.7). The activation of class II fusion machineries also requires a proteolytic cleavage,
but in contrast to class I fusion proteins not the fusion protein itself but a second,
associated glycoprotein is proteolytically processed. Moreover, the fusion peptide
of class II proteins is located internally and not at or proximal to the N-terminus
(Figure 4.7) (23).
Flavivirus protein E
The receptor-binding and membrane-fusion protein E of ﬂaviviruses is a well cha-
racterized example for class II viral fusion proteins. Conformational changes in E
drive the fusion reaction that is essential for virus entry. Crystal structures of the E
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protein ectodomain in its pre- and postfusion conformation have provided insights
into the ﬂavivirus fusion process (48, 66).
Prefusion conformation of E
Structures of recombinant and truncated E protein dimers of DENV 2 and DENV 3
and E monomers of WNV have been published (45, 47, 52, 79). The crystal struc-
ture of the soluble fragment of protein E (sE), released by trypsin treatment of TBE
virions and lacking the around 100 carboxyterminal amino acids, has been solved at
2 A˚ resolution (52). The atomic structure of the ﬂavivirus E protein ectodomain in
its prefusion conformation will be explained in detail on the basis of the TBEV E
dimer (Figure 4.7).
At neutral pH the E protein forms head-to-tail homodimers lying ﬂat on the vi-
ral membrane (Figure 4.7). The crystal structure of the external, crystallized part
(residues 1 – 395) lacking the stem-anchor region shows a signiﬁcantly diﬀerent ar-
chitecture compared to class I fusion proteins. The gently curved dimer is oriented
parallel to the membrane and spans the overall dimensions of approximately 150 A˚
x 55 A˚ x 30 A˚ (52). The polypeptide chain of each monomer of sE is composed
of 3 individual domains, with a high β-sheet content (Figure 4.7 A, C). Domain I
lies at the centre of the protomer structure. It forms a β-sandwich, stabilized by
two disulphide bridges. The axis of the β-sandwich lies nearly parallel to the viral
membrane (52). Two protruding loops are stabilized by three disulphide bridges and
build the elongated dimerization domain II. At the tip of this elongated, ﬁnger-like
domain a glycine-rich hydrophobic sequence is located. This highly conserved region
has been identiﬁed as the fusion loop which is important for target membrane inter-
action during fusion. The C-terminal domain (DIII) of the soluble E structure has
an immunoglobulin-like fold with a single disulphide bridge. DIII is linked to the
central domain I by a 15 residue-linker-segment. This domain protrudes away from
the outer protein surface and has thus been implicated in receptor-binding (52, 66).
In diﬀerent crystal forms, slightly variable angles between the distinct domains have
been observed, indicating a signiﬁcant degree of DIII-ﬂexibility.
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Figure 4.7: Prefusion conformation of ﬂavivirus E protein. (A) Top view of dimeric, prefusion
structure of TBEV E protein, residues 1-395 (52), (pdb ID 1SVB). (B) Schematic representation
of E protein organization on mature ﬂavivirus particles (adapted from (34)). (C) Side view of
dimeric, prefusion structure of TBEV E protein, residues 1-395. (D) Schematic representation of
full-length E protein dimer (side view). (E) Linear representation of E protein architecture. The
black star indicates the C-terminus of the crystal structure. Individual domains are labeled in one
monomer, color code: domain I (DI), red; domain II (DII), yellow; fusion peptide (fp), orange;
domain III (DIII), ﬂexible linker, purple; blue; stem, cyan and transmembrane domain (TMD),
green; The membrane is colored in grey.
The dimer is largely stabilized by interactions between two opposite DII domains.
The conserved fusion peptide dips with a tryptophan into a hydrophobic cave, pro-
vided by the DI/III interface of the opposite subunit (Figure 4.7). This arrangement
prevents the fusion peptide from membrane interactions in its neutral pH confor-
mation. The fusion loop is additionally covered by an oligosaccharide, which is
positioned above the DI/III crevice (22, 45, 52, 79).
E protein homodimers form the outer layer of a mature virion, where 180 copies
of protein E are organized in a smooth, icosahedral shell of metastable homodimers.
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Three parallel dimers are arranged in 30 rafts in a herringbone-like orientation (39).
The lipid bilayer is largely inaccessible and covered by E (Figure 4.7 B). Cryo-electron
microscopy (EM) image reconstructions have shed light on the conformation of the
C-terminal part of the E protein, which is absent in the sE crystal structures. The
EM data indicate, that the stem, which connects the sE with the transmembrane
region is composed of two α-helices linked by a loop. In the prefusion conformation
of E, this stem is cooped between the ectodomain and the viral membrane (78).
The transmembrane domain spans the viral bilayer twice, resembling the shape of a
helical hairpin (Figure 4.7 D) (78).
Postfusion conformation of E
Upon exposure to low pH, the ﬂavivirus E protein undergoes a dimer-to-trimer tran-
sition. The irreversible trimerization of the soluble protein fragment could only be
achieved by exposing the sE dimer to acidic pH in the presence of liposomes (65).
The crystal structure of the solubilized sE trimer has been solved and characterized
in detail for TBEV, DENV 1 and DENV 2 (Figure 4.8) (9, 46, 49).
In the postfusion trimer, the monomers are oriented perpendicular to the bilayer.
The conformational change of E includes no major refolding of the individual do-
mains but rather a rearrangement of the domains relative to each other (66). Relative
to domain I, domain II rotates 19° around the DI/II junction, resulting in a long rod,
composed of DI and DII (9). The residues of the fusion loop, which are exposed to
the solvent, are supposed to interact with the lipid heads of the outer leaﬂet of the
target membrane. A more dramatic relocation is observed for domain III, enabled
by the ﬂexible linker between DI and DIII. Compared to the neutral pH conforma-
tion, DIII relocates from the top of the monomer to the side of the trimeric core
and ﬂips against the interface of two protomers. As a consequence, the C-terminus
of the crystallized fragment is directed towards the viral membrane (9). In the full
length protein the distance between the DIII/stem linker and the bilayer is about
50 A˚, which is proposed to be bridged by the stem region (50 aa). With regard to
membrane fusion, the E protein membrane anchor and the target membrane-inserted
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Figure 4.8: Postfusion conformation of ﬂavivirus E protein. (A) Side view of trimeric, low pH
structure of TBEV E protein, residues 1-401 (9), (pdb ID 1URZ). The carboxy-terminus of the
crystallized part is indicated by a black star. (B) Schematic representation of full-length E protein
trimer (side view). Helix 1 and helix 2 of the stem are labeled with H1 and H2, respectively.
Individual domains are labeled in one monomer: DI, red; DII, yellow; fp, orange; DIII, blue; stem,
cyan and transmembrane domain, green; viral membrane, light grey; host membrane, dark grey.
fusion peptide would be juxtaposed in the postfusion structure. The overall trimer
resembles the hairpin-like arrangement of class I fusion proteins, suggesting a similar
fusion mechanism (9).
Proposed class II membrane fusion mechanism
Flavivirus membrane fusion is a fast and eﬃcient process (66). X-ray crystallo-
graphy data and cryo-EM structures of E in its pre- and postfusion conformation
in addition to biochemical studies have provided insight into the class II membrane
fusion mechanism. Based on these results a class II fusion model has been developed
(Figure 4.9) (66).
Flaviviruses enter the host cell via receptor-mediated endocytosis. The acidic pH
in the endosome causes the dissociation of the E protein homodimers into monomers
and the exposure of the previously buried fusion peptide for interaction with target
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Figure 4.9: Proposed class II fusion process. (A) Prefusion dimer, oriented parallel to the viral
membrane. (B) Low-pH-induced dimer dissociation and target membrane interaction of exposed
fps. (C) Trimerization and zippering of the stem along the trimer core. (D) Hemifusion inter-
mediate. (E) Trimeric, hairpin structure of postfusion protein with fusion peptides and TMDs
juxtaposed in the fused membranes (modiﬁed from (66)).
membranes (Figure 4.9 B) (66). At this stage, the viral and the host membrane are
bridged by the fusion protein. The extension of the stem is thought to facilitate the
insertion of the fusion peptide into the target membrane (32). Further structural
changes involve the relocation of domain III from the top of the rod-like structure
to the side of DI, the zippering of the stem along DII and the formation of stable
postfusion trimers with the membrane anchors and the fusion peptides juxtaposed
in the fused bilayers (Figure 4.9 C-E) (66). This model illustrates the transition of
the E protein homodimer to a postfusion trimer, including a transient hemifusion
intermediate in which just the outer leaﬂets have merged (66).
4.2.1.3 Class III viral fusion proteins
Glycoproteins from rhabdo-, baculo- and herpesviruses have been assigned to the
third class of viral fusion proteins (7). These proteins have a diﬀerent structural
organization, in comparison to class I and II proteins (53). Class III fusion proteins
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combine structural features of the ﬁrst two previously identiﬁed classes (53). The
proteins are trimers, built up by multidomain protomers. The α-helical coiled-coil
core of the trimer is a characteristic attribute of class I fusion proteins. In contrast,
the presence of extended β-hairpins with hydrophobic tips are features of class II
fusion proteins (26). Vesicular stomatitis virus is an enveloped, bullet-shaped virus,
assigned to the family Rhabdoviridae. The virus enters the cell through the endocytic
pathway, mediated by the viral glycoprotein G (54). The crystal structure of the
vesicular stomatitis virus glycoprotein G (ectodomain) has been solved in its pre-
and postfusion conformation (53, 54). In the prefusion state, the trimeric G protein
exhibits the shape of a tripod with the fusion loops at the tip of each leg, directed
towards the viral membrane. Each protomer carries two fusion loops, which are not
buried, but separated from each other (54). The protomers are composed of four
individual domains (Figure 4.10 A). Domain I is an elongated β-sheet-rich domain;
domain II is composed of antiparallel β-sheets; domain III has a long, central α-helix,
involved in trimerization at the top of the molecule, whereas domain IV consists
entirely of β-sheets (53).
Upon exposure to low pH, the G protein undergoes dramatic structural rearrange-
ments to an inverted cone-shape like organization. Domain I, carrying the fusion
loops, ﬂips to the opposite side of the molecule for target membrane interaction (Fi-
gure 4.10 B). The refolding of the trimerization domain II drives the projection of
the C-terminal part, resulting in the postfusion conformation with transmembrane
region and fusion domain at the same side of the molecule (Figure 4.10 C). Domain
II undergoes a dramatic change in fold, whereas domain I, III and IV maintain their
folds and rather change their orientation relative to each other. It has been shown
that VSV G can be present in at least three diﬀerent conformations: the native
prefusion state, an activated intermediate state (target membrane interaction) and
the postfusion structure. In contrast to class I and class II fusion proteins, the con-
formational change of VSV G is reversible. There is an equilibrium between these
conformations, depending on the present pH (Figure 4.10) (54).
Despite the structural diversity among the viral fusion protein classes, in all cases,
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Figure 4.10: Conformational changes in VSV G class III fusion protein. Individual domains of the
protomer are labeled with diﬀerent colors: domain I, purple; domain II, green; domain III, yellow;
domain IV, orange. Fusion loops are indicated by an asterisk. C- and N-termini are labeled with
C and N, respectively. (A) Prefusion structure of VSV G ectodomain. (B) Extended intermediate
structure of VSV G ectodomain. (C) Postfusion conformation of VSV G ectodomain. C- terminus
and the fusion loops are oriented towards the same direction (adapted from (7)).
known so far, fusion protein transition results in a hairpin structure with the viral
membrane anchor and target membrane-inserted fusion peptide at the same end of
the postfusion trimer (73).
4.3 Membrane-proximal regions of viral fusion proteins
Viral fusion proteins of all three classes are composed of oligomeric ectodomains
anchored to the viral membrane by transmembrane domains (TMD). A striking
characteristic of many viral fusion proteins is a long sequence stretch, rich in aromatic
residues, which precedes the TMD (43). This external part of viral fusion proteins
is deﬁned as the membrane-proximal external region (MPER). MPERs of several
viral fusion proteins share common features. Secondary structure analyses of these
regions with respect to the distribution of hydrophobic patches have often revealed
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an amphipathic character. Such structural elements have been predicted to promote
hydrophobic interactions between diﬀerent protein elements or tend to appear at
water-membrane intersections (43). Studies on diﬀerent viruses have shown that
MPERs of viral fusion proteins can promote membrane fusion. They can transfer
the energy of conformational changes in proteins towards membranes or participate
in membrane destabilization (43).
The membrane-proximal region of the class I fusion protein gp41 of human im-
munodeﬁciency virus (HIV) has been studied extensively. It has been shown that
the helical element contributes to the thermostability of the trimer and is thought to
be involved in membrane interactions (10). Mutations of aromatic MPER residues
in gp41 inhibited fusion in a late stage of the fusion process (55). A peptide derived
from the HIV envelope glycoprotein (env) MPER has been identiﬁed as an eﬀec-
tive fusion inhibitor (16). This synthetic peptide, named T20 binds to intermediate
structures of the env ectodomain and thereby inhibits HIV entry (35).
The MPER of the VSV class III fusion protein G has been shown to increase the
fusion activity of heterologous viral fusion proteins, by inducing lipid-mixing of the
outer leaﬂets (30).
The MPER of alphavirus class II fusion protein E1, the so-called E1 stem, has
been shown to pack against the core of the trimeric ectodomain in a late stage of the
fusion process. The stem of the E1 class II fusion protein contributes to the stability
of the trimer and enhances the fusion inhibition eﬀect of exogenous domain III (40).
These examples clearly demonstrate the importance of MPERs in viral membrane
fusion.
Membrane-proximal region of the ﬂavivirus E protein
The membrane-proximal region of the ﬂavivirus E protein, the stem, connects the
ectodomain with the double transmembrane anchor (Figure 4.7 D). The stem com-
prises approximately 50 residues and forms two amphipathic alpha helices (H1 and
H2), connected by a short linker (64, 78). Secondary structural elements of ﬂavivirus
E proteins of mature dengue virus particles, including the stem-anchor region, have
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been visualized by cryo-EM of DENV 2 (Figure 4.11) (78). These images have il-
lustrated that in the dimeric prefusion conformation of E the two stem helices are
sandwiched in the interface of the E protein ectodomain and the viral membrane.
The helices are arranged parallel to the viral surface and partly buried in the outer
lipid bilayer. The hydrophobic patches of the helices are directed towards the mem-
brane, allowing an interaction with the lipid phosphate head groups (66, 78).
Figure 4.11: Diagram of the full-length dengue virus protein E in the prefusion conformation. Helix
1 (H1) and helix 2 (H2) of the stem are oriented in parallel to the viral membrane, interacting with
the outer leaﬂets of the bilayer (adapted from ((78)).
Figure 4.12: Helix 1 (H1) of the stem modeled into postfusion structure. H1 was modeled into
the groove of the trimer interface. The conserved residues are directed towards DII of the same
polypeptide chain. The carboxy-terminus of the crystallized part is labeled with a white star
(adapted from (9)).
The structure and orientation of the crystallized postfusion sE trimer indicates,
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that the stem region would follow the sE C-terminus and bridge the gap (50 A˚) to
the viral surface (Figure 4.8 B) (9). The stem helices would run along the vertical
groove provided by neighbouring subunits of the trimer, bringing TM anchor and
target membrane-inserted fusion peptides into close proximity (Figure 4.8 B) (9).
During membrane fusion the stem is supposed to zipper along domain II forcing
the bending of the two opposing membranes (Figure 4.9 C) (9, 66). Biochemical
studies have shown that the stem contributes to the stability of the postfusion trimer
(69). The presence of stem-H1 was crucial for trimerization in the absence of target
membranes (5).
H1 of the stem was modeled into the DII/DII* interface of the truncated trimeric
postfusion structure (Figure 4.12) (9). In this conformation, speciﬁc intramolecular
interactions between highly conserved stem residues and the domain II have been
proposed (9). The conserved, aromatic residue F403 is predicted to interact with a
highly conserved pocket, formed by the domain II residues W219 and L223. Further
contacts are thought to form between the stem and the postfusion trimer core (9).
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The general aim of this work was to gain more detailed information about the
mechanism of ﬂavivirus membrane fusion. Crystal structures of the pre- and post-
fusion conformation of soluble truncated forms of the fusion protein E (sE), lacking
the stem-anchor region, provided important information about viral class II fusion
proteins (9, 45–47, 49, 52, 79). High-resolution structures of the E protein stem,
which connects the crystallized part to the transmembrane anchor are not available,
so far. Structures of fusion intermediate stages of E are also not known. The cur-
rently existing ﬂavivirus fusion model is therefore hypothetical and based on the
truncated pre- and postfusion structures and on biochemical data. According to this
ﬂavivirus fusion model, the stem is hypothesized to zipper along domain II in the
course of hairpin formation (66), but direct experimental evidence for stem-trimer
core interactions does not exist. In this thesis, we want to gain new insights into the
role of the stem region in ﬂavivirus fusion, using mutational analyses of viruses and
recombinant subviral particles (RSP) of tick-borne encephalitis virus.
Speciﬁc aim part I
Bressanelli et al. used the trimeric postfusion conformation of the truncated E pro-
tein and modeled the ﬁrst helix of the stem into the existing structure. H1 was ﬁtted
into a vertical groove, located at the oligomer interface. In this model, conserved
stem residues oriented towards DII of the same protomer, supporting the idea that
the stem might interact with the trimer core in the postfusion conformation (9). To
investigate possible stem-trimer core contact sites, we will mutate residues of the
stem and DII, which were predicted to interact with each other in the postfusion
trimer. To examine these mutations and their eﬀect on possible stem-interactions
and ﬂavivirus fusion, we will use the experimental system of TBEV RSPs. RSPs are
noninfectious particles, which exhibit fusion properties similar to virions and are an
established model to examine ﬂavivirus fusion and fusion-related processes (12).
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Speciﬁc aim part II
Although the RSP system is an elegant system to study ﬂavivirus fusion and fusion-
related processes, it cannot provide data about infectivity. It was therefore the
objective of the second part of the thesis, to extend the ﬁndings obtained in the RSP
system to the infectious virus system and to investigate the impact of mutations on
virus infectivity and fusion. For that purpose, mutations with an eﬀect on RSP fu-
sion activity and additional substitutions at the proposed DII/stem interaction site
will be introduced into the infectious clone of TBEV. Infectivity of virus mutants
will be analyzed to supplement the RSP data.
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6.1 Introduction
A characteristic feature of ﬂavivirus infection is the production and release of non-
infectious subviral particles (SVP) - also designated Slowly-Sedimenting Hemagglu-
tinin (SHA) - along with the infectious virions (61, 70). SHA are capsidless particles
which consist of a lipid bilayer in which the two viral glycoproteins M and E are
integrated. Subviral particles can also be produced in a recombinant form by trans-
fecting mammalian cells with a recombinant plasmid, which allows the coexpression
of the two TBE envelope proteins E and prM (4). Two size classes of RSPs have
been characterized (6). The larger particles have similar dimensions as virions. The
smaller and prevalent species, which is approximately 30 nm in diameter has been
characterized in detail. 60 copies of E protein are present as homodimers arranged
in a T = 1 icosahedral symmetry (Figure 6.1) (19). It was shown, that E in RSPs
has the same antigenic and oligomeric structure as that in infectious virions (56).
RSPs are assembled in the ER as immature particles and traverse the same matura-
tion and secretion pathway as virions (12, 56). The fully functional E proteins are
capable of undergoing an irreversible dimer-to-trimer transition and the associated
conformational and structural changes could also be observed (56). Cover et al. used
ﬂuorescently-labeled RSPs and measured particle fusion with liposomes after acidi-
ﬁcation, in order to examine the fusion characteristics of RSPs. The data showed,
that RSPs have a rate and extent of low-pH-induced fusion that is similar to viral
particles (12). Thus, RSPs provide a useful non-infectious experimental system to
investigate the ﬂavivirus fusion mechanism. Using a mutational analysis on RSPs of
TBEV, the conserved loop of E at the tip of domain II has been identiﬁed as the fu-
sion peptide (2). In this project we want to make use of RSPs to obtain information
about the role of the E protein stem in ﬂavivirus fusion.
The ﬂavivirus E protein stem is hypothesized to be important in early and late
stages of fusion. Cryo-EM studies on West Nile virus with antibody fragments
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Figure 6.1: Flaviviral recombinant subviral particles (RSP). (A) Schematic representation of a
RSP cross-section. RSPs are composed of a lipid-bilayer with the glycoproteins prM/M and E on
the particle surface. Heterodimeric prM/E arrangement of immature RSPs (left). After particle
maturation in the TGN, E protein homodimers cover the particle surface (modiﬁed from (66)). (B)
Schematic representation, demonstrating the icosahedral symmetry of the E protein arrangement
in the mature RSP (adapted from (34)).
demonstrated that the stem probably supports fusion peptide insertion into target
membranes by extending from the viral membrane upon dimer dissociation (32).
Later in the fusion process, the stem is speculated to zip along the body of the
trimer after relocation of domain III (58, 66) and might thereby provide part of
the energy for membrane merger (Figure 4.9). Consistent with this hypothesis, it
has been shown that the addition of dengue virus recombinant DIII alone was not
suﬃcient to inhibit dengue virus fusion, whereas DIII together with H1 of the stem
(Figure 4.8) inhibited fusion of dengue viruses (40). Moreover, peptides derived
from the stem region of the dengue virus E protein have been shown to bind to
the truncated stem-less sE trimer and thereby function as fusion inhibitors at a
stage prior to hemifusion and fusion-pore formation (58). Using the RSP system, we
introduced mutations into the stem and into the parts of domain II located at the
predicted stem-trimer core interface and investigated the eﬀect of these mutations
on fusion. An established control system was implemented to guarantee the quality
and maturity of the used RSPs.
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6.2 Materials and Methods
6.2.1 Mutagenesis of RSPs
Mutations were introduced into the SV-PEwt plasmid by site-directed mutagene-
sis, using the Gene Tailor Kit of Invitrogen. Mutagenesis primers are listed in table
6.1. The plasmid contained the TBEV prM and E genes under the control of the
SV40 early promoter (1). To conﬁrm the presence of only the desired mutations
at codon positions 223, 403, 406, 421 and 434 the whole prM/E sequence of each
plasmid was veriﬁed by sequencing.
Table 6.1: Oligonucleotide sequences.
F = forward primer, R = reverse primer.
Oligonucleotide name Sequencea
L223I-F CAT AGG GAC TGG TTC AAT GAT ATA
GCT CTG CCA T
L223I-R ATC ATT GAA CCA GTC CCT ATG GAC
CTG CC
F403I-F GG AGC AGC ATC GGA AGG GTT ATC
CAA AAG ACC
F403I-R AAC CCT TCC GAT GCT GCT CCC TTT
TTG G
T406A-F C GGA AGG GTT TTC CAA AAG GCC
AAG AAA GGC A
T406A-R CTT TTG GAA AAC CCT TCC GAT GCT
GCT CCC
W421I-F CA GTG ATA GGA GAG CAC GCC ATA
GAC T TC GGT T
W421I-R GGC GTG CTC TCC TAT CAC TGT CAG
TCT TTC
G434N-F GA GGC TTT CTG AGT TCA ATT AAC
AAG GCG GTA C
G434N-R AAT TGA ACT CAG AAA GCC TCC AGC
AGA ACC
a Nucleotides were synthesized by VBC BIOTECH.
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6.2.2 Production of RSPs
The recombinant wild-type (WT) and mutant plasmids were electroporated into
COS-1 cells for RSP production as described previously (56). COS-1 cells were
grown in Dulbecco’s modiﬁed eagle medium (DMEM), supplemented with 5% PSG
(penicillin-streptomycin-glutamine) and 10% fetal calf serum and maintained in
DMEM with 5% PSG. 48 hours post transfection, RSPs were harvested from cell cul-
ture supernatants and pelleted by ultracentrifugation. For coﬂotation assays, RSPs
were further puriﬁed by sucrose gradient centrifugation (56). For membrane fusion
assays, RSPs were metabolically labeled with 1-pyrene hexadecanoic acid (Invitro-
gen), as described previously (12).
6.2.3 Quality control of RSPs
Secretion of RSPs into the supernatant of transfected cells was quantiﬁed with
a four-layer enzyme-linked immunosorbent assay (ELISA) after sodium dodecyl-
sulphate solubilization at 65°C for 30 min (25).
The maturation state (presence of prM) of RSPs was analyzed by Western blot-
ting (20). Equal amounts of RSPs (standardized to E protein) were serially diluted
and loaded onto a 15% polyacrylamide gel. Proteins were separated under SDS
denaturing conditions and blotted onto a polyvinylidene diﬂuoride membrane with
a semidry blotting apparatus (Bio-Rad). The content of prM protein was detected
with a polyclonal anti-TBEV serum and anti-rabbit-immunoglobulin G- alkaline per-
oxidase (Amersham). Proteins were visualized using SigmaFast DAB tablets (59).
E protein conformation and folding was investigated by epitope mapping with
a set of E protein speciﬁc monoclonal antibodies (mabs). WT and mutant RSPs
(0.5 μg/ml E protein) were captured on solid phase by a guinea pig anti-TBE virus
immunoglobulin (Ig) and tested with a predetermined dilution of each mab. A
peroxidase-labeled rabbit anti-mouse Ig was used to detect the reactivity of the
preparations to the mabs in a four-layer ELISA (6, 56).
38
6.2 Materials and Methods
6.2.4 Fusion assay
Fusion activity of WT and mutant RSPs was tested with an in vitro fusion assay.
Unilamellar liposomes (pore size: 200 nm) composed of phosphatidylcholine, phos-
phatidylethanolamine and cholesterol (molar ratio 1:1:2) were mixed with pyrene-
labeled RSPs in a ﬂuorimeter cuvette at 37℃ (2, 68). Fluorescence was continuously
monitored for 60 s with a ﬂuorescence spectrophotometer (LS-50B; Perkin Elmer)
at a wavelength of 343 nm. Fusion of RSPs with liposomes was initiated by acidiﬁ-
cation with MES to a ﬁnal pH of 5.4. Fusion activity was determined by recording
the decrease in the pyrene-excimer-ﬂuorescence, due to dilution of the probe into
unlabeled liposomes. The fusion extent was calculated by deﬁning the initial ﬂuo-
rescence as 0% fusion and the signal of the solubilized RSP-liposome mixture as 100%
fusion. Solubilization was achieved by the addition of the detergent octa(ethylene
glycol)-n-dodecyl monoether (Sigma-Aldrich) (20, 68).
6.2.5 Coﬂotation assay
Puriﬁed RSPs were incubated with liposomes at a ratio of 1 μg E to 200 nMol
lipids (composition as described above). The mixture was acidiﬁed to pH 5.4 by
the addition of MES and incubated for 15 min at 37℃. The samples were back-
neutralized with 150 mM triethanolamine to pH 7.8 and mixed with sucrose to
yield a concentration of 20% (wt/wt). This sample (0.6 ml) was put onto a 1ml 50%
sucrose cushion and further overlaid with 1.4 ml 15% sucrose and 1 ml of 5% sucrose.
All sucrose solutions were prepared in TAN buﬀer, pH 8.0 (20, 65). The gradients
were centrifuged for 2 hours at 4℃ at 50000 rpm in a SW 55 Beckman Coulter rotor.
Fractions of 200 μl were collected by upward displacement with a Piston Gradient
Fractionator (BioComp Instruments Inc.) and the E protein in each fraction was
determined in a four-layer ELISA after treatment with 0.4% sodium dodecyl sulphate
at 65°C for 30 min (25).
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6.2.6 Dimer-trimer transition assay and trimer stability assay
For E protein trimerization, RSPs (3 μg E protein) were acidiﬁed by the addition
of MES to a ﬁnal pH of 5.4 (2, 3). After 10 min at 37℃ the sample was back-
neutralized with 150 mM triethanolamine and solubilized with 1% Triton X-100.
The mixture was incubated for 1 hour at room temperature and subjected to a
7%-20% (wt/wt) continuous sucrose gradient containing 0.1% Triton X-100. The
gradients were centrifuged for 20 hours at 38000 rpm at 15℃ in a SW 40 Beckman
Coulter rotor. Fractions of 600μl were collected and analyzed by a quantitative four-
layer ELISA. To test the thermostability of trimers, low-pH-treated and solubilized
RSPs were incubated for 10 min at 70℃ before subjected to sedimentation analysis,
as described above.
40
6.3 Results and Discussion
6.3 Results and Discussion
6.3.1 Generation and quality control of mutant RSPs
To investigate the role of the protein E stem region in ﬂavivirus membrane fusion,
we introduced mutations into the stem and into the part of domain II, which was
predicted to form the interface with the stem in the postfusion trimer (9). We
targeted highly conserved residues in both helices of the stem, in the linker between
the two helices, and in domain II. The targeted residues are illustrated in a ﬂavivirus
E protein alignment in Figure 6.2 A.
We wanted to investigate the impact of the introduced mutations on ﬂavivirus
fusion and fusion-related properties, but the introduced mutations could theoretically
also interfere with other processes than fusion, e.g. correct E processing, folding and
oligomerization and particle formation, maturation and secretion (20). In order to
assure, that the mutations do not aﬀect a wild-type (WT)- like character at neutral
pH, we subjected the mutant particles to a set of quality control experiments (20).
To assess the structural integrity of the mutant E proteins, their reactivity with
monoclonal antibodies (mabs) was analyzed by a four-layer ELISA and compared
to the WT binding pattern (20). The used mabs react with E protein epitopes
on domain I, domain II or domain III and are suitable to detect conformational
diﬀerences (20, 34). The binding proﬁles of two mutants and WT are shown in
Figure 6.3. All mabs recognized mutant and WT particles similarly, as shown by
the comparable absorbance-values obtained in the ELISA.
The maturation state of mutant RSPs was further analyzed by Western Blotting,
using a polyclonal serum raised against TBEV, as described previously (20). The
amount of prM protein on ﬂaviviral particles is an indication for the maturation
state of the particles. The detection limit of prM in serially diluted RSP samples
(standardized to E protein) was compared to the prM content of WT RSPs and
immature RSPs (20). As shown in Figure 6.4 with mutant L223I, the prM content
was similar to WT, whereas in immature RSPs, carrying a mutation in the furin
cleavage site of prM, a signiﬁcantly higher amount of the precursor protein is present.
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Figure 6.2: E protein sequence alignment and residue substitutions. (A) The amino acid sequences
of JEV, WNV, DENV, YFV and TBEV E proteins were aligned. Conserved regions are marked in
red. Mutated residues are highlighted in orange and labeled. (B, C) E protein residue substitutions
and their position.
Immature TBE virus was applied as a prM standard in the ﬁrst line of mutant and
WT RSP blots. The mutants, which passed the quality control and were subject
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Figure 6.3: Binding proﬁles of mabs in a four-layer ELISA. Determination of reactivities of E
protein speciﬁc mabs with WT and mutant RSPs. The absorbance at 490 nm is plotted on the
y-axis.
to further investigation are depicted in Figure 6.2 B and C. Substitution of residue
W219 (A, V, I, Y, N) completely abolished particle secretion. At position L223,
several amino acid exchanges have been performed (A, I, V, Y). Only the mutation
to isoleucine resulted in the release of RSPs. The secretion of L223I mutant RSPs
was reduced compared to the WT (approximately 20 - 35% of WT), but the secreted
particles were mature (Figure 6.4), with WT-like E protein conformation at neutral
pH (Figure 6.3).
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Figure 6.4: RSP maturation state analysis by Western Blotting. The precursor protein prM is
present on immature particles. The maturation state (prM content) of RSPs was detected by
Western Blot analysis. RSPs were serially diluted in two-fold steps to determine the prM detection
limits. Immature virus (prM-v) was applied into the ﬁrst lane, used as a prM standard. PrM
content of mutant RSPs (here L223I, middle blot) was compared to WT RSPs (upper blot) and
immature RSPs (lower blot).
6.3.2 Characterization of mutant RSPs
6.3.2.1 Fusion activity of mutant RSPs
To test the eﬀect of the mutations in the stem and domain II on the overall
fusion activity, WT and mutant RSPs were metabolically labeled with 1-pyrene
hexadecanoic acid and tested in an in vitro fusion assay (Figure 6.5). Fluorescence-
labeled WT and mutant RSPs were incubated with unlabeled liposomes, exposed
to neutral or acidic pH and ﬂuorescence was continuously monitored for 60 seconds
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(12). As shown in Figure 6.6 A, at pH 5.4 WT RSP fusion occurred within seconds,
whereas the L223I mutant displayed a strong reduction of fusion. All other mutants
exhibited the same extent and rate of fusion as WT. Fusion extents are shown in
Figure 6.6 B.
Figure 6.5: Schematic of fusion assay using pyrene-labeled RSPs and unlabeled liposomes. 1-
pyrene hexadecanoic acid is a ﬂuorescent dye which integrates into membranes, thus allowing to
detect lipid-mixing. In labeled RSPs, pyrene is present as excimers. Upon fusion of the RSP
membrane with the liposomal membrane, the ﬂuorescent dye is diluted, resulting in a decrease in
the pyrene-excimer ﬂuorescence.
The residue L223 was predicted to be involved in the interaction of domain II
with helix 1 of the stem region in the postfusion conformation (9). To determine
at which stage the fusion process is interrupted we used diﬀerent experimental tools
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that allowed us to analyze the eﬀect of mutations on the fusion process step by step.
Figure 6.6: Fusion of pyrene-labeled WT and mutant RSPs with liposomes at acidic pH. Pyrene-
labeled subviral particles were mixed with liposomes. The decrease in pyrene-excimer-ﬂuorescence
after acidiﬁcation was monitored continuously for 60 s. (A) Fusion curve of WT (blue) and L223I
mutant (green) RSP at pH 5.4. (B) Extent of fusion of mutant RSPs compared to WT (100%)
after 60 s.
6.3.2.2 Target membrane interaction of mutant RSPs
To investigate the early steps of membrane fusion (dimer dissociation, fusion pep-
tide exposure and interaction with target membranes) we tested all mutant RSPs
and the WT in a liposome coﬂotation assay. With this experiment, we measured the
interaction of RSPs with target membranes after exposure to acidic pH, resembling
the initial step of the fusion process. Puriﬁed RSPs were mixed with liposomes.
After exposure to acidic pH, samples were back-neutralized and applied to sucrose
step gradients. The appearance of protein E at the top of the gradient, indicating
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liposome binding, was determined by a four-layer ELISA (25, 65). As shown in
Figure 6.7, acidiﬁcation of WT and mutant RSPs in the presence of liposomes led
to a quantitative association with target membranes. These data indicate that the
initiation of membrane fusion was not disturbed by any mutation investigated in this
work. This is consistent with the existing fusion model, supporting the idea that
stem-zippering occurs after fusion peptide exposure and target membrane interaction
(58, 66).
Figure 6.7: Low-pH-induced coﬂotation of RSPs with liposomes. WT and mutant RSPs were
mixed with liposomes and exposed to acidic pH. After back-neutralization the mixture was sub-
jected to sucrose step gradient centrifugation. The gradients were fractionated and the amount
of E protein in each fraction was quantiﬁed in a four-layer ELISA. The extent of low-pH-induced
coﬂotation of protein E with liposomes is plotted relative to the WT (100%).
6.3.2.3 Low-pH-induced trimerization of E protein mutants
Since the L223I mutation does not inﬂuence the initial steps of fusion, the impair-
ment, observed in overall fusion (Figure 6.6 A) has to occur at a later stage of the
fusion process, such as the trimer formation of E. To investigate the eﬀect of muta-
tions in E on low-pH-induced trimerization, WT and mutant RSPs were exposed to
acidic pH, back-neutralized and solubilized. The oligomeric state of E was analyzed
by sedimentation in sucrose gradients (3). At neutral pH, E sedimented as a dimer.
All mutants, including the fusion-impaired L223I mutant were able to convert into
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Figure 6.8: Low-pH-induced trimerization of protein E in WT and mutant RSPs. WT and mutant
RSPs were exposed to pH 5.4 or pH 8.0, back-neutralized, solubilized and the oligomeric state
of the E protein was analyzed by rate zonal sucrose gradient centrifugation. The sedimentation
direction is from left to right. At pH 8.0, E sediments as a dimer (dashed lines). In all cases (WT
and mutants) quantitative E trimerization was observed at low pH (solid lines). (A) Quantitative
E protein trimerization of L223I mutant. (B) Low-pH-induced E protein trimerization of WT RSP.
(C) Extent of trimer formation of all mutant RSPs, compared to WT (100%)
trimers at low pH (Figure 6.8). Although previous studies with truncated forms of
E have shown that the stem-H1 is required for trimerization in the absence of target
membranes (5), the introduction of single and double mutations into the stem in the
context of full-length E did not aﬀect this process.
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6.3.2.4 Thermostability of E protein mutant trimers
It was shown previously that the stem-anchor region contributes to the thermo-
stability of E protein trimers (69). In order to assess whether the introduced mu-
tations had an eﬀect on the stability of the mutant trimers, we performed thermal
denaturation experiments. For this purpose, RSPs were exposed to acidic pH, back-
neutralized, solubilized, heated for 10 minutes to 70℃ and then subjected to sedimen-
tation analysis. Under these conditions, the sedimentation of two mutants (T406A
and W421I) was comparable to the WT and not aﬀected by high temperature (Fi-
gure 6.9). In contrast, the four mutants L223I, F403I, G434N and F403I-G434N were
partially denatured at this temperature as indicated by a reduced trimer peak and
the accumulation of aggregated material in the pellet (Figure 6.9). These ﬁndings
conﬁrm the important role of the stem in the overall stability of the postfusion trimer,
as single residue substitutions can impair the stability of the postfusion trimer.
Interestingly, mutant trimers containing the L223I and F403I substitution showed
a higher amount of aggregated E compared to the other mutants with reduced stabi-
lity (Figure 6.9). These two residues have been suggested to be interaction partners
in the trimeric postfusion conformation (9). Bressanelli et al. predicted, that ac-
cording to their model the stem residue F403 neatly ﬁts into the hydrophobic pocket
on the DII surface, formed by W219/L223 in the postfusion structure (9). This
intramolecular interaction is predicted to be at the initial contact site of DII and
stem-H1 (Figure 6.10), based on the model (Figure 4.12). Replacement of the pocket
residue L223 by isoleucine led to reduced thermostability of the trimer and impaired
fusion activity (Figure 6.6). Amino acid exchange of the interaction partner in the
stem (F403I) also resulted in reduction of trimer stability, but did not aﬀect fusion
with liposomes (Figure 6.6 B).
We therefore hypothesized, that the L223I mutation disturbs the interaction be-
tween the DII pocket and stem residue F403, as a consequence of an altered pocket
geometry or steric hindrance. The bulky phenylalanine (F403) might not ﬁt into the
altered DII pocket anymore. The disturbed interaction between the trimer core and
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Figure 6.9: Thermostability of WT and mutant protein E trimers. Low-pH-induced and solubilized
E trimers were heated to 70 ℃ for 10 min and subjected to sedimentation analysis. The gradients
were fractionated and the amount of E protein in each fraction was determined by a quantitative
four-layer ELISA. The sedimentation direction is from left to right. The last fraction represents the
pellet (P), resuspended in 0.6 ml buﬀer, according to a single fraction volume. Trimers incubated
at 37 ℃ are shown in black solid lines. Trimers heated to 70 ℃ are shown in grey dashed lines.
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the N-terminus of the stem might prevent the correct positioning of the stem during
zippering. This could lead to the observed impairment in trimer stability and fusion
activity. In order to ﬁnd out if residues L223 and F403 actually interact with each
other in the trimer and if this interaction site is important for trimer stability we con-
structed a double mutant (L223I-F403I), combining the altered DII-pocket (L223I)
and a smaller, already characterized substitution of the phenylalanine (F403I). We
wanted to test whether deﬁciencies in trimer stability and fusion, obtained with
the L223I mutant, can be compensated by an additional substitution in the stem
(F403I). We hypothesized that the smaller, yet hydrophobic isoleucine might allow
interaction.
Figure 6.10: Schematic representation and structures of predicted DII/stem interaction site. (A)
The residues W219 and L223 form a pocket, predicted to interact with the stem residue F403 (9).
(B, left) Surface view of DII pocket. (B, right) Side chains of pocket residues are shown in sticks.
Color code: W219, magenta; L223, green (pdb 1URZ). C-terminus of crystallized part is indicated
with a black star.
6.3.3 Characterization of double mutant L223I-F403I
We wanted to characterize the constructed mutant in fusion and fusion-related
processes and compare it to the L223I single mutant, to ﬁnd out if there is an inter-
action between the residues in the trimer and if the additional stem mutation can
compensate the reduced trimer stability and fusion deﬁciency, observed for the L223I
mutant. We therefore analyzed the fusion activity of the L223I-F403I mutant with
liposomes and compared it to the single mutants. Consistent with the hypothesis,
the double mutant exhibited enhanced fusion activity compared to the single mu-
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tant L223I, but was still lower than the WT, as shown in Figure 6.11 A. Despite this
apparent compensatory eﬀect, the double mutant still displayed less eﬃcient fusion
than the WT. This could be due to an impairment of early fusion stages (target mem-
brane interaction) or later steps, such as trimerization and lipid-mixing. In order to
ﬁnd out, if the early stages of the fusion process are aﬀected in the double mutant,
we investigated the interaction with target membranes in the coﬂotation assay. WT
and mutant RSPs were mixed with liposomes, acidiﬁed and subjected to sedimenta-
tion analysis. Target membrane interaction was detected by ELISA (Figure 6.11 B).
E protein found in fractions 4 to 9 corresponded to membrane-associated E protein.
Like all other mutants investigated in this work, the L223I-F403I mutant coﬂotated
like WT. To investigate low-pH-induced trimer formation and trimer thermostabi-
lity, E protein trimerization was performed as described before. The mutant RSPs
showed complete dimer-to-trimer transition (Figure 6.11 C), but after exposure to
70 ℃ the trimer peak was reduced and E protein accumulated in the gradient pellet
(Figure 6.11 D). In good agreement with the fusion results, the L223I-F403I mutant
trimer was more stable than the L223I mutant (Figure 6.11 D). Consistent with
our hypothesis, the L223I-F403I double mutant exhibited enhanced fusion activity
compared to the single mutant L223I in the in vitro fusion assay and intermediate
trimer thermostability. Apparently, the double mutation in both DII pocket and
stem signiﬁcantly enhances binding, thereby increasing the thermostability of the
trimer and fusion activity of the particle.
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Figure 6.11: Characterization of L223I-F403I mutant RSP. (A) Fusion kinetic curve of L223I-F403I
mutant RSP (red) compared to WT (blue) and single mutants L223I (green) and F403I (orange).
(B) Acidic-pH-induced coﬂotation of WT (blue line) and L223I-F403I (red line) mutant RSP. E
protein found in fractions 4 to 9 represents RSPs coﬂotated with liposomes. (C) Sedimentation
analysis of low-pH-induced trimer formation of L223I-F403I mutant. The sedimentation direction
is from left to right. At neutral pH L223I-F403I mutant E sedimented as a dimer. Quantitative
trimer formation was observed at acidic pH. (D) Sedimentation analysis of L223I-F403I E protein
trimers, exposed to 70℃ in comparison to WT and single mutant trimers.
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Taken together, our data provide the ﬁrst evidence that modiﬁcations in domain
II and the stem can result in decreased fusion activities. It has been argued, that
zippering of the stem along domain II is important to provide the energy for mem-
brane merging (66). Our data imply that structural alterations in the DII/stem
interface by single-residue substitutions, lead to decreased trimer thermostability
that subsequently provides less energy to drive the fusion process. Consistent with
these results, thermal denaturation studies on the class I fusion protein gp41 of HIV
showed, that the presence of the membrane-proximal external region (MPER) of
gp41, like the stem of class II proteins, also signiﬁcantly increases trimer stability
(10). This is in good agreement with fusion inhibition studies using exogenous do-
main III + stem-H1 of dengue virus E protein. Dengue virus 2 fusion inhibition was
not observed with DIII alone, but in the presence of DIII together with stem-H1 (40).
However, for the closely related alphavirus Semliki Forest virus (SFV), DIII alone
was suﬃcient to inhibit membrane fusion (40). Although both proteins are classiﬁed
as class II viral fusion proteins and are highly similar in structure, the stem of ﬂa-
vivirus E is composed of two α-helices, whereas the alphavirus stem is shorter and
rearranges from an unstructured state into an α-helical element only upon trimeriza-
tion (21). Mutational analysis of SFV E1 stem demonstrated that neither a speciﬁc
stem residue, nor the conserved length is essential for membrane fusion (41), indi-
cating a diﬀerence in the requirement of this structural element between alpha- and
ﬂaviviruses.
By interfacial hydrophobicity analysis MPERs of several viral fusion proteins were
characterized. Functional studies showed that both, the MPER of gp41 (class I) and
VSV G (class III) contribute to the fusion reaction (43), indicating a similar function
to the ﬂaviviral E protein stem. The gp41 MPER was shown to contribute to the
thermostability of the trimer and the x-ray structure indicates an involvement in
membrane interactions during membrane fusion (10). The MPER of class III VSV
G can increase the fusion activity of heterologous viral fusion proteins. This region
induces lipid-mixing of the outer leaﬂets (30).
For ﬂaviviruses, it was shown that stem-derived peptides bind to stem-less trimers
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and thus trap the structure in a fusion intermediate state (58). Moreover, in a recent
study, peptides derived from dengue 2 virus E, containing the proposed domain II
pocket sequence, inhibited cell entry (13). Peptides have been investigated as fusion
inhibitors and their eﬀects have been described for class I fusion proteins, as well
(16). Peptides which bind to intermediate structures of the fusion proteins are
used to inhibit viral entry, such as HIV (35). Fusion inhibitors in general display an
interesting tool for antiviral therapy, as they could eﬀectively inhibit viral replication
at an early stage. Based on the present study, it would be interesting to synthesize
and target small molecules to the domain II pocket. A more extensive analysis of the
residues involved in the zippering of the stem along DII would allow the development
of further strategies to prevent stem-driven trimer stabilization.
A manuscript with the title The role of the stem region in ﬂavivirus membrane
fusion, describing these data is in preparation.
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7.1 Introduction
We used recombinant subviral particles (RSPs) to show, that the interaction be-
tween the pocket-forming residues W219 and L223 of DII and F403 of the stem
is important for E protein postfusion trimer stabilization and fusion activity. The
signiﬁcance of these ﬁndings was further tested using an infectious virus system.
Despite the fact that RSPs are an established model to study viral fusion, there
are important diﬀerences between RSPs and virions. RSPs are smaller and ex-
hibit a diﬀerent quaternary structure compared to virions. The major diﬀerence is
the particle geometry. Whereas on virions 90 E protein dimers are organized in a
herringbone-like icosahedral symmetry, on RSPs 30 E protein dimers are arranged
in a T=1 icosahedral lattice (19). RSPs have a higher curvature and E protein
dimers are less densely packed on the particle surface (34). Fusion of RSPs with
liposomes is a very elegant, yet simpliﬁed method. Virus infection is a complex
process including diﬀerent environmental factors, which cannot be employed in the
RSP system. TBEV enters the cell by receptor-mediated endocytosis followed by
fusion from within the early endosome (42). Fusion-impaired virions, which are not
able to completely fuse with the membrane of early endosomes, might be traﬃcked
to late endosomes with diﬀerent environmental parameters, such as a lower pH and
diﬀerent lipid compositions (77).
Infectious cDNA clones of TBEV provide the possibility to introduce speciﬁc mu-
tations into the viral genome and investigate the eﬀect of these mutations on virus
infectivity and other processes of the viral life cycle. The ﬂavivirus genome of strain
Neudoerﬂ was stably inserted as cDNA into a plasmid vector suitable for bacterial
expression (44). A full-length TBEV cDNA clone and two shorter plasmids, carrying
either the 5’ or 3’ region of the TBEV genome allow the recombinant introduction of
mutations into the TBEV genome. By site-directed mutagenesis, mutations can be
engineered into the smaller partial clones and then transferred into the full-length
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clone by restriction and ligation. Stable, full-length cDNA clones can then be tran-
scribed to viral RNA in vitro. It has been shown, that WT TBEV RNA transcripts
from the cDNA clone are infectious and induce the production of infectious pro-
genies, when transfected into suitable cells. Virus obtained from cDNA clones has
been characterized according to its antigenic structure, growth and virulence, and
did not reveal any diﬀerence compared to the parental virus strain (44). Using this
approach, infectivity of mutant viruses were analyzed and compared to the data
obtained for RSPs.
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7.2 Materials and Methods
7.2.1 Cells and virus
BHK-21 cells (ATCC CCL10) were grown at 37℃ in 5% CO2 in Eagle’s mini-
mal essential medium, supplemented with 5% fetal calf serum (FCS), 1% glutamine
and 0.5% neomycin (growth medium) and maintained in Eagle’s minimal essential
medium, supplemented with 1% FCS, 1% glutamine, 0.5% neomycin and 15 mM
HEPES (maintenance medium). For all experiments, the western subtype TBE virus
prototypic strain Neudoerﬂ (GenBank accession number U27495) (44) was used as
a template for mutagenesis and wild-type (WT) control.
7.2.2 Mutant construction
Table 7.1: Oligonucleotide sequences.
F = forward primer, R = reverse primer.
Oligonucleotide name Sequencea
W219A-F CT TGG CAG GTC CAT AGG GAC GCG
TTC AAT GAT C
W219A-R GTC CCT ATG GAC CTG CCA AGC CGT
TGG AAG
L223A-F CA TAG GGA CTG GTT CAA TGAT GCG
GCT CTG CCA T
L223A-R ATC ATT GAA CCA GTC CCT ATG GAC
CTG CC
L223I-F CAT AGG GAC TGG TTC AAT GAT ATA
GCT CTG CCA T
L223I-R ATC ATT GAA CCA GTC CCT ATG GAC
CTG CC
F403I-F GG AGC AGC ATC GGA AGG GTT ATC
CAA AAG ACC
F403I-R AAC CCT TCC GAT GCT GCT CCC TTT
TTG G
a Nucleotides were synthesized by VBC BIOTECH.
All plasmids used for cloning were derived from cDNA of the TBEV strain Neu-
doerﬂ. Mutations in the structural protein E of TBEV were ﬁrst engineered into
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the plasmid pTNd/5’, containing the 5’ part of the viral genome in a pBR322 plas-
mid vector. The mutated insert was cut and transferred into the plasmid pTNd/c,
carrying a full-length cDNA insert of TBEV. Mutagenesis was performed with the
Gene Tailor System (Invitrogen).
Brieﬂy, the template plasmid pTNd/5’ was methylated and mutations were in-
troduced by site-directed mutagenesis. Mutagenesis primers are listed in table 7.1.
The mutations were transferred into the full-length cDNA clone pTNd/c using the
restriction sites SalI and SnaBI (for substitutions at positions 219 and 223) or SnaBI
and ClaI (for substitution at position 403) (44). All plasmids were ampliﬁed in the
Escherichia coli strain HB101 and plasmid preparations were made by the use of the
Qiagen puriﬁcation system. The constructs were checked by sequence analysis with
an automated DNA sequencing system (PE Applied Biosystems, GA3100) (37).
7.2.3 RNA transcription
The engineered pTNd/c plasmids were used as templates for in vitro transcription
with the T7 Megascript Kit (Ambion) according to manufacturer´s protocol. The
template DNA was digested by incubation with DNase I. RNA was puriﬁed by the use
of the RNeasy Mini Kit (Qiagen) and quantiﬁed by spectrophotometric measurement
(37).
7.2.4 Virus stock production in BHK-21 cells
For production of virus stocks, equal amounts of RNA were electroporated into
BHK-21 cells with a Gene Pulser (Bio-Rad) applying previously described settings
(17). Virus stocks were harvested from cell culture supernatant 48 hours post trans-
fection, cleared by centrifugation at 10000 rpm for 20 min at 4℃ in a Beckman
JA-12 rotor and stored at -80℃. For sequence analysis, RNA was isolated from the
stock and the region encoding for the structural proteins was checked after reverse
transcription with a cDNA synthesis system (Roche Applied Science) (37).
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7.2.5 Immunoﬂuorescence
Expression of viral proteins was determined by immunoﬂuorescence staining with
a polyclonal serum, predominantly recognizing viral E protein. BHK-21 cells trans-
fected with viral RNA were disseminated into 24-well plates, containing micro-
scope coverslips. Transfection eﬃciency and protein expression was detected 1
day post electroporation. Cells were permeabilized by acetone-methanol (1:1) ﬁxa-
tion and serially incubated with a rabbit polyclonal anti-TBEV and a ﬂuorescein-
isothiocyanate-conjugated anti-rabbit antibody (Jackson immune Research labora-
tory) (59).
7.2.6 Focus assay
Infectious titers of viral stocks were determined by infection of BHK-21 cells with
serial dilutions of virus in maintenance medium. Conﬂuent monolayers of BHK cells
were incubated for 3 hours with virus dilutions. Virus was removed and cells were
covered with 3% carboxymethyl-cellulose-overlay in maintenance medium. Fifty-
three hours post infection the overlay was removed and cells were ﬁxed with acetone-
methanol (1:1). Cells were further treated by successive incubations with a polyclonal
rabbit anti-TBEV serum and with goat anti-rabbit IgG-alkaline phosphatase. Sig-
maFast Red TR/Naphtol AS-MX tablets were used as substrate to visualize the foci
(59).
7.2.7 Quantiﬁcation of E protein secretion
The concentration of E protein in virus stock preparations was determined by a
quantitative four-layer ELISA. Microtiter plates (Nunc) were coated with 2.5μg/ml
anti-TBEV IgG (guinea pig) for at least 48 hours at 4℃. The samples and the
TBEV standard were solubilized with 0.4% sodium dodecyl sulphate (SDS), seri-
ally diluted and transferred onto the coated plates. A polyclonal rabbit anti-TBE
serum was used as a second antibody and a horseradish peroxidase-linked donkey
anti-rabbit IgG served as a detection antibody. The reaction with the substrate
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orthophenyldimine/H2O2 was stopped by the addition of 2N H2SO4. The optical
density was measured with an ELISA reader. Wells lacking the antigen served as
blank (25).
For particle quantiﬁcation, 3 μg total E in virus stock were applied to 5-30%
(wt/wt) sucrose gradients and centrifuged for 70 min at 38000 rpm at 4℃ in a
Beckman SW 40 rotor. Fractions of 600 μl were taken by upward displacement and
the E protein in each fraction was determined again in a four-layer ELISA (described
above).
7.2.8 RNA isolation and quantiﬁcation
Cell culture supernatants of primary transfected cells were cleared 48 hours post-
transfection and RNA was isolated using a QIAamp vial RNA Mini kit (QIAGEN),
according to manufacturers protocol (37). RNA was directly transcribed into cDNA
by the use of the iScriptcDNA Synthesis Kit (BioRad), according to the supplied
protocol. The cDNA was quantiﬁed under real-time PCR conditions (PE applied
Biosystems). Serial dilutions of an already quantiﬁed and in vitro transcribed RNA
were used for standard curve generation.
7.2.9 Liposomes
Liposomes, composed of phosphatidylcholine (Avanti Polar Lipids, Alabaster,
AL), phosphatidylethanolamine (Avanti Polar Lipids, Alabaster, AL) and choles-
terol (SIGMA) in a 1:1:2 molar ratio in chloroform were dried to a thin ﬁlm with
a rotary evaporator in a high vacuum. The lipid ﬁlm was hydrated in liposome
buﬀer (10 mM triethanolamine, 140 mM NaCl, pH 8.0) and subjected to 5 cycles of
freeze and thawing. Liposomes were extruded (21 passes) through two 200 nm poly-
carbonate membranes (pore size: 200 nm) by the use of a Liposofast syringe type
extruder (Avestin, Ottawa, Canada) (68). For the content-mixing assay, liposomes,
containing trypsin were produced by the use of hydration buﬀer supplemented with
trypsin (6000U/liposome production) (SIGMA).
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7.2.10 Production of pyrene-labeled viruses
Metabolically labeled WT and mutant TBE virus preparations were produced by
infection of primary chicken embryo cells with WT or mutant virus stock from BHK-
21 cells. Cells were grown and maintained in medium, supplemented with 1-pyrene
hexadecanoic acid. Characterized viral stocks, produced in BHK-21 cells were used
for infection. Virus was harvested 48 hours post infection and puriﬁed by two cycles
of sucrose density gradient centrifugation (12).
7.2.11 Quality control of pyrene-labeled viruses
The maturation state of virus preparations was analyzed with two mabs, B4 and
8H1, which are directed to E protein and prM, respectively. Microtiter plates (nunc)
were coated with 2.5μg/ml anti-TBEV IgG (guinea pig) for at least 48 hours at 4℃.
The samples and in addition immature and mature TBEV preparations, which were
used as controls were put onto the coated plates in a 0.5μg/ml concentration. Mabs
B4 and 8H1 in serial dilutions were used as second antibodies and a horseradish
peroxidase-linked rabbit anti-mouse IgG was used for detection with the substrate
orthophenyldimine/H2O2. The reaction was stopped by the addition of 2N H2SO4.
The optical density was measured with an ELISA reader. Wells with antigen, but
lacking the mab served as blank.
7.2.12 Virus fusion with plasma membrane
Plates with conﬂuent monolayers of BHK-21 cells containing coverslips, were
washed with cold binding medium (TCM Hank’s medium, supplemented with 0.5%
neomycin, 1% glutamine and 20 mM NH4Cl, pH 7.5). TBEV (1 μg E protein/well)
was diluted in binding medium and bound to BHK-21 cells for 100 min on ice. Un-
bound virus was removed by washing with binding medium and fusion was induced
by exposure to acidic pH for 2 min/37℃ using binding medium, supplemented with
MES. Subsequently, cells were incubated for 3 hours in MEM, supplemented with
2% FCS and 50 mM NH4Cl. For further 24 hours, the NH4Cl concentration was
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reduced to 20 mM (adjusted from (40)). Viral protein expression was detected by
immunoﬂuorescence staining as described above.
7.2.13 Content-mixing assay
Virus fusion with liposomes, containing trypsin was detected by Western Blot.
TBEV (1 μg E protein) was mixed with 2 mM of trypsin-containing liposomes in
liposome buﬀer. The reaction volume of 240 μl was divided into 3 equal aliquots
(acidic pH, neutral pH, solubilized). The samples were adjusted by the addition of
MES, TAN and Triton X-100 respectively, and incubated for 5 min at 37℃. After
neutralization with TEA the mixture was incubated for 75 min at 37℃ for trypsin
digestion. The reaction was stopped by the addition of 5x Laemmli sample buﬀer
and heated to 95℃ for 5 min before applied to SDS-PAGE (adjusted from (51)).
The integrity of viral capsid protein was analyzed by immunoblotting after apply-
ing 20 μl of sample onto SDS-PAGE under denaturing conditions. The separated
protein bands were transferred to a polyvinylidene diﬂuoride membrane with a Bio-
Rad Trans-Blot semidry transfer apparatus. Proteins were detected by consecutive
incubation with a rabbit anti-TBEV C protein serum, directed against the capsid
protein and anti rabbit immunoglobulin G-alkaline peroxidase (Amersham).
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7.3 Results and Discussion
7.3.1 Generation of E protein (L223I and L223I-F403I) mutants of TBE virus
By the use of recombinant subviral particles of TBE virus, we were able to identify
an interaction site between the stem and DII. We generated E protein mutants
which exhibited a reduction in E trimer thermostability and were strongly impaired
in fusion activity, as detected in an in vitro fusion assay with liposomes. Since
RSPs are capsidless, noninfectious particles, they do not allow the examination of
particle infectivity. To investigate the eﬀect of mutations on virus infectivity and
fusion, we engineered the respective mutations (L223I and L223I-F403I) into the
TBE virus genome, by site-directed mutagenesis. The presence of the mutations
was conﬁrmed by sequencing. Viral full-length RNAs were transcribed in vitro and
quantiﬁed. Equal amounts of viral RNA were introduced into BHK-21 cells by
electroporation. Cell culture supernatants after primary transfection were harvested
48h post electroporation and clariﬁed by centrifugation.
7.3.2 Characterization of L223I and L223I-F403I mutant viruses
To conﬁrm the genomic sequence of the virus in the cell culture supernatants
after transfection, RNA was isolated and used as a template for cDNA synthesis and
sequence analysis. The entire structural-protein-region was checked by sequencing of
the cDNA to exclude additional mutations. Apart from the introduced mutations,
no additional mutations were found. The cell culture supernatants were further used
to characterize mutant virus infectivity.
7.3.2.1 Infectious properties of virus mutants
The RSP mutants L223I and L223I-F403I exhibited reduced fusion activity. Since
fusion is a prerequisite for infection, we aimed to test whether the mutations that
impair fusion of RSPs, have an inhibitory eﬀect on infection, when introduced into
viral particles. We thus transfected BHK-21 cells with mutant viral RNA and sub-
sequently measured the quantity of intracellular viral proteins by immunostaining
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(Figure 7.1, upper panel). Cells transfected with mutant RNAs exhibited similar im-
munoﬂuorescence signals in comparison to cells transfected with WT TBEV RNA.
Detection of intracellular viral protein is dependent on RNA replication and pro-
tein translation (36). Thus, mutant and WT RNAs were transfected into cells with
comparable eﬃciencies and were competent to perform RNA replication and protein
translation.
To see whether the transfected cells produced infectious progenies, the super-
natants were transferred onto fresh cells and investigated by immunostaining 24
hours post infection. As shown in Figure 7.1 (lower panel), both mutants revealed
a positive immunoﬂuorescence staining, indicating that both mutant viruses (L223I
and L223I-F403I) are infectious. To exclude the possibility of additional mutations
that might account for the infectious phenotype, RNA was isolated from the super-
natant of infected cells (1. passage) and sequenced after reverse transcription. No
additional mutations were found.
Figure 7.1: Immunoﬂuorescence analysis. E protein expression was visualized in transfected and
infected BHK-21 cells by immunofuorescence staining.
The same supernatants, investigated by immunoﬂuorescence after primary trans-
fection, were analyzed by focus forming assays (described in Materials and Methods)
to determine the infectious titers of mutant and WT viruses. The infectious units
are shown in Figure 7.2. Both mutant viruses exhibited similar infectious titers as
the corresponding WT production. The titer of the L223I mutant virus, in the su-
pernatant of transfected cells was slightly lower compared to WT. These analyses
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Figure 7.2: Infectivity of supernatants of primary transfected cells. The infectious units were
determined in a focus assay.
revealed, that cells transfected with RNA were able to produce infectious progenies.
7.3.2.2 Speciﬁc infectivities of virus mutants
In order to directly compare infectious properties of mutant and WT viruses, it
was necessary to determine their speciﬁc infectivities, by quantifying the number of
viral particles and relating these to the respective virus titers (Figure 7.2). We used
two diﬀerent approaches to quantify viral particles.
E protein quantiﬁcation
The ﬁrst approach to quantify viral particles was based on E protein quantiﬁcation
by an E protein-speciﬁc four-layer SDS-ELISA. The E protein concentrations in the
supernatants of cells transfected with mutant RNA are shown in Figure 7.3 A, B.
E protein could be present in particulate and soluble form. In order to quantify
viral particles, it was necessary to assess the proportion of soluble and particle-
associated E protein in the cell culture supernatants after transfection, by rate gra-
dient centrifugation. For that purpose, equal amounts of total E protein were sub-
jected to a continuous sucrose gradient centrifugation and fractionated. The amount
of E protein in each fraction was quantiﬁed by ELISA. Two pairs of mutant and WT
preparations had suﬃcient E protein concentrations to be subjected to sedimentation
analysis (Figure 7.4 A and B). In all investigated cell culture supernatants, a large
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Figure 7.3: E protein concentration in supernatants of cells transfected with viral RNA. The
amount of E protein was determined in a quantitative four-layer ELISA.
Figure 7.4: Analysis of E protein distribution in cell culture supernatants of cells transfected with
viral RNA. 3 μg total E protein was subjected to sedimentation analysis.
proportion of secreted E protein was not incorporated into viral particles and was
thus detected in the upper fractions. Most likely these fractions represent soluble
and lipid-associated E protein. E protein associated with viral particles was detected
in smaller amounts in fractions 10 - 14, where it co-localizes with the control sample
of puriﬁed virus. A small peak in fractions 7 and 8 most probably represents sub-
viral particles secreted from transfected cells. Mutant L223I showed a distribution
pattern similar to WT (Figure 7.4 A). The E protein distribution pattern of the
L223I-F403I mutant indicated a slightly higher proportion of particulate E protein
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compared to WT (Figure 7.4 B). Since the E protein concentration was not high
enough in all cell culture supernatants to be analyzed by gradient centrifugation, we
used an additional approach to quantify viral particles.
Quantiﬁcation of viral RNA
An alternative way to determine speciﬁc infectivity is to quantify viral RNA, which
is incorporated into viral particles, present in the supernatant of transfected cells.
For this purpose, RNA was isolated from such supernatants and detected by quan-
titative PCR (qPCR). RNA copies/ml of both mutants and the corresponding WT
are shown in Figure 7.5. The amount of RNA copies in the supernatant of trans-
fected cells was similar for both mutant viruses and WT virus, indicating that similar
amounts of viral particles were present.
Figure 7.5: Quantiﬁcation of viral particles in the supernatant of primary transfected cells. RNA
copies were quantiﬁed by quantitative PCR analysis.
To determine speciﬁc infectivities, the values obtained from particle quantiﬁcation
were put into relation to the infectivity titers (ﬀu) of the same supernatants, deter-
mined by focus forming assays (Figure 7.2). In Figure 7.6, speciﬁc infectivities of
the mutants are depicted relative to the corresponding WT preparation. Figure 7.6
A shows the results deduced from particle-associated E protein measurements and
Figure 7.6 B those from determinations of RNA.
With both approaches, the L223I mutant virus exhibited a reduced speciﬁc infec-
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Figure 7.6: Speciﬁc infectivity. The speciﬁc infectivities of mutant viruses are depicted relative
to the WT, produced in parallel. (A) Calculation of speciﬁc infectivities based on the ratio of
particle-associated E protein per focus forming unit (results of a single experiment). (B) Speciﬁc
infectivities based on the ratio of RNA copies per focus forming unit (mean of 3 independent
experiments).
tivity relative to the WT. However, the observed diﬀerence in infectivity was lower
than expected, given that the same mutation in the RSPs almost completely abo-
lished fusion activity. A possible explanation could be that mutations aﬀected fusion
activity of the virus much less dramatically than that of the RSP, perhaps due to
diﬀerences in particle geometry of RSPs and virions. Therefore, it would be impor-
tant to investigate in which way these mutations aﬀected virus fusion in the same in
vitro fusion assay performed with RSPs.
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7.3.2.3 Production and quality control of labeled viruses
To investigate the corresponding fusion characteristics of viruses carrying muta-
tions with an eﬀect on RSP fusion, pyrene-labeled virions were produced in chicken
embryo ﬁbroblasts as described previously (12, 24). Supernatants of transfected
BHK-21 cells were used for infection of pyrene-labeled chicken embryo cells. In or-
der to determine the maturation state (prM content) of the virus preparations, we
tested their reactivity with serial dilutions of two mabs (B4 and 8H1) in a four-layer
ELISA. Mab B4 is directed to E protein DIII, whereas mab 8H1 reacts with the prM
protein, which is present on immature particles. As controls, well-characterized ma-
ture and immature virions were used (Figure 7.7 A). The DIII speciﬁc mab exhibited
a higher reactivity with mature virions than the prM-speciﬁc mab 8H1, whereas the
binding pattern was reversed with immature particles (Figure 7.7 A). The pyrene-
labeled WT and mutant virus preparations displayed a binding proﬁle more similar
to the immature than the mature virus control (Figure 7.7 B). Since the presence
of uncleaved prM aﬀects fusion, no conclusive data could be obtained with these
preparations. The reason for the production of immature particles has to be investi-
gated and further attempts will be made to produce mature, pyrene-labeled mutant
viruses.
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Figure 7.7: Maturation state analysis of pyrene-labeled virus preparations. The reactivity of two
mabs B4 and 8H1, directed to E protein and prM, respectively in serial dilutions with pyrene-labeled
virus productions was determined in a four-layer ELISA. (A) Binding proﬁles of mabs with mature
and immature virus controls. (B) Reactivities of mabs with pyrene-labeled virus preparations. The
absorbance at 450 nm is plotted on the y-axis. Binding proﬁle of E protein directed mab B4 is
shown in solid lines. Binding proﬁle of prM directed mab 8H1 is drawn in dashed lines.
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7.3.3 Generation of E protein (W219A and L223A) mutants of TBE virus
Utilizing the RSP system, we were able to identify an interaction between residues
L223 in DII and F403 in the stem in the trimeric postfusion conformation. Together
with W219, L223 forms a hydrophobic pocket, into which the residue F403 ﬁts
(Figure 6.10). The amino acid exchange L223I was the only replacement of leucine
223, which resulted in the release of mature and properly folded RSPs. In the case of
residue W219, all introduced substitutions of residue W219 (A, V, I, Y, N) completely
abolished particle secretion. The RSP system thus did not allow the investigation
of other mutations at this site. However, it has been shown, that mutations, that
abolished particle secretion in the RSP system, allowed the generation of infectious
virions (20, 50). Moreover, the infectious virus system provides the possibility of
the occurrence of resuscitating mutations that might appear during mutant virus
passaging. The location of such compensatory mutations could provide additional
information about stem-trimer core interactions.
Therefore, additional pocket substitutions were introduced into the infectious clone
of TBEV (W219A and L223A) and the mutants were characterized with respect to
their infectivity and genetic stability.
7.3.4 Characterization of W219A and L223A mutant viruses
7.3.4.1 Infectious properties of virus mutants
BHK-21 cells, transfected with viral RNA were analyzed by immunoﬂuorescence
staining 24 hours post electroporation (Figure 7.8). Positive signals in immunoﬂuo-
rescence staining were comparable for both, mutant and WT viruses, indicating a
similar RNA replication and viral protein expression level (Figure 7.8, upper panel).
In order to investigate whether the transfected cells released infectious virions, the
supernatants were harvested and transferred onto fresh BHK-21 cells (Figure 7.8,
middle panel) and analyzed by immunoﬂuorescene 24 hours post infection. Transfer
of cell culture supernatant from W219A transfected cells did not result in infec-
tion, indicated by the negative immunoﬂuorescence staining. Infection with the
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supernatant of cells, transfected with L223A viral RNA was dramatically reduced
compared to the WT.
Figure 7.8: Immunoﬂuorescence analysis. E protein expression and virus infectivity was visua-
lized by immunoﬂuorescence staining. Supernatants, which were subject of further analyses are
highlighted in orange.
Cell culture supernatants were further passaged ﬁve times in BHK-21 cells to see
whether resuscitating mutations might occur. After the ﬁfth passage, cells were ﬁxed
and immunoﬂuorescence staining was performed (Figure 7.8, lower panel). In the
case of the W219A mutation, viral protein expression was still negative, whereas the
infectivity of the ﬁfth L223A virus passage was substantially improved (almost 100%
infected cells), indicating that either resuscitating mutations or a reversion to WT
have occurred.
7.3.4.2 Speciﬁc infectivities of virus mutants
In order to compare the infectious properties of mutant and WT viruses, we de-
termined the speciﬁc infectivity of cell culture supernatants of cells transfected with
L223A and WT RNA and the supernatant harvested after L223A virus passaging
(Figure 7.8, highlighted in orange). Speciﬁc infectivities were determined by relating
viral RNA to the respective infectivity titers, determined in focus forming assays (Fi-
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gure 7.9 A). The infectious titer of L223A virus was dramatically reduced compared
to the WT, whereas the supernatant of the ﬁfth L223A passage displayed infectious
units similar to WT.
Figure 7.9: Speciﬁc infectivity determination of supernatants of transfected cells (L223A, WT) and
supernatant after L223A passaging (SN 5.P). Viral particle quantiﬁcation and speciﬁc infectivity.
(A) Virus titers were determined in focus forming assays. (B) Viral particles were quantiﬁed by
RNA isolation and quantiﬁcation. (C) The speciﬁc infectivities were calculated based on the ratio
of RNA copies per focus forming unit.
The number of RNA copies in the supernatant of transfected cells (L223A, WT)
and in the supernatant harvested after L223A virus passaging are shown in Figure
7.9 B. To determine the speciﬁc infectivity, the number of viral RNA copies was
put into relation to the respective titer (Figure 7.9 C). The speciﬁc infectivity of
the supernatant harvested after L223A virus passaging was signiﬁcantly improved
compared to that of the engineered mutant L223A and similar to WT.
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In order to ﬁnd the reason for the signiﬁcant increase in infectivity, we checked
the sequence of viral RNA in the supernatant harvested after L223A passaging. For
that purpose, RNA was isolated from the cell culture supernatant of the ﬁfth L223A
passage. Sequencing of cDNA showed that passaging of L223A virus had resulted in
a mutation at position 223 to valine (by a single base exchange) (Figure 7.10).
Figure 7.10: Resuscitating mutation at E protein amino acid 223. The original residue L223 was
replaced by alanine. After virus passaging a resuscitating mutation at the same position to valine
occurred.
Taken together, substitution of the DII pocket residues W219 and L223 to an
alanine dramatically impaired the formation of infectious particles. The reduced
speciﬁc infectivity observed for mutant L223A could be the consequence of either
a deﬁciency in virus assembly, or an impaired fusion activity. The data indicate,
that the mutation L223A had an eﬀect on both processes. The number of viral
RNA copies in the supernatant of transfected cells was reduced compared to the
76
7.3 Results and Discussion
WT (Figure 7.9 B), suggesting that the mutation had an eﬀect on particle assembly.
This is to some extent consistent with the RSP data, where introduction of the
L223A mutation completely abolished particle secretion. But a deﬁciency in virus
assembly alone cannot explain the observation, that viral particles, which are present
in the supernatant of transfected cells (Figure 7.9 B) are drastically reduced in their
infectivity (Figure 7.9 A). The signiﬁcantly reduced speciﬁc infectivity suggests an
eﬀect of the L223A mutation on virus fusion, which might be a consequence of the
alteration in the DII pocket. Data obtained with the RSP system demonstrated
an interaction of the pocket forming residues W219 and L223 with the stem residue
F403. Substitution of L223 by an isoleucine had a strong eﬀect on RSP fusion, which
was partially compensated by additionally replacing the proposed stem interaction
partner F403 by an isoleucine, suggesting that the isoleucine at position 223 changed
the DII pocket in that way, that the bulky F403 cannot bind to the pocket anymore.
The smaller isoleucine at 403 might allow some interaction with the pocket. There
was also an eﬀect of the L223I mutation on virus infectivity, albeit lower than on
RSP fusion. The replacement of the same residue L223 by an alanine showed a
drastic impact on the speciﬁc infectivity. The smaller alanine might not allow the
interaction with the stem, which might aﬀect zippering of the stem along DII and
prevent the correct positioning of the stem to obtain a stable postfusion trimer.
This deﬁciency in virus fusion might be the reason for the provoked resuscitating
mutation of A223 to a valine, which was possible by a single base change. Valine is a
hydrophobic amino acid with two methyl groups, very similar to the original amino
acid leucine (Figure 7.10). L223V seems to restore the DII pocket and might thus
improve the interactions with the stem residue F403 (Figure 6.10), demonstrated by
the strongly increased speciﬁc infectivity in comparison to the L223A mutant.
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7.3.5 Establishment of full fusion assays with virus
The current ﬂavivirus fusion model includes a transient hemifusion state in which
just the outer leaﬂets have merged (Figure 4.9). In this thesis, we used a lipid-
mixing assay with ﬂuorescence-labeled RSPs and liposomes (Figure 6.5), but this
assay cannot distinguish between hemifusion and full fusion, in which a fusion pore
has been formed. In order to allow a diﬀerentiation between these two stages of
fusion, two full fusion assays were established. Since RSPs are capsidless and do not
possess the properties (nucleocapsid, infectivity) required for these assays, infectious
virus particles were used for the full fusion test establishment.
7.3.5.1 Virus fusion with the plasma membrane
The acidic pH in the endosome triggers fusion of the viral with the endosomal
membrane after virus uptake via receptor-mediated endocytosis (42). It has been
shown, that full fusion can be measured by infection after artiﬁcial low-pH-induced
fusion at the plasma membrane (40). For that purpose, virions were pre-bound
to BHK-21 cells at 4℃. The samples were than acidiﬁed for 2 minutes at 37℃
and incubated for 24 hours at 37℃ in the presence of 20 mM NH4Cl to prevent
secondary infections through the endocytic pathway. Infected cells were visualized by
ﬂuorescence microscopy using polyclonal anti-TBEV sera. The experimental strategy
is demonstrated in Figure 7.11 and in detail explained in Materials and Methods.
Cells without virus (mock) and cells incubated with virus, but maintained at neutral
pH were used as controls for pH-dependent fusion.
As shown in Figure 7.12, full fusion of the viral with the plasma membrane of
BHK-21 cells could be induced by acidiﬁcation of virions, which were pre-bound
to cells, as indicated by a positive immunoﬂuorescence signal (Figure 7.12 upper
panel). Only a single infected cell was detected, when virus was incubated with cells
and maintained at neutral pH, indicating that NH4Cl almost completely abolished
natural virus infection (Figure 7.12 lower panel). We therefore conclude, that low-
pH-induced virus fusion with the plasma membrane and subsequent detection of viral
protein expression can be used as an experimental approach to study full fusion of
78
7.3 Results and Discussion
TBE virus.
Figure 7.11: Schematic of full fusion assay. Virus fusion with the plasma membrane of BHK-21
cells was induced by acidic pH. Viral protein translation was detected by immunoﬂuorescence.
Figure 7.12: Full fusion activity of TBE virus. Fusion of virus with the plasma membrane, induced
by acidic pH was detected by immunoﬂuorescence staining of viral protein expression.
79
7 Part II (infectious system)
7.3.5.2 Content-mixing assay
An alternative assay to measure full fusion was based on content-mixing (51). For
that purpose, trypsin-containing liposomes were mixed with virions. In the intact
virus, the capsid is protected by the viral membrane against external trypsin. Upon
acidiﬁcation of the liposome-virus mixtures and low-pH-induced membrane fusion
the nucleocapsid will enter the liposome and trypsin will then be able to degrade the
capsid proteins. The degradation of C can be measured by SDS-PAGE and Western
blot using a C protein speciﬁc polyclonal serum.
For that purpose, liposomes were loaded with trypsin and mixed with puriﬁed
TBE virus. The mixture was split into three aliquots and exposed to acidic pH,
maintained at neutral pH and solubilized with Triton X-100 (lysis of membranes
and C protein degradation without fusion), respectively. After ﬁve minutes at 37°C,
the acidiﬁed sample was back-neutralized. The aliquots were maintained at 37°C for
further 75 minutes for trypsin digestion. The reaction was stopped by the addition
of sample buﬀer and subjected to SDS-PAGE and subsequent immunoblotting with
a TBEV C protein speciﬁc rabbit serum. The experimental procedure is illustrated
in Figure 7.13 and described in detail in Materials and Methods.
Figure 7.14 shows that at low pH, the capsid protein has been degraded completely.
Lysis of membranes with Triton X-100 also resulted in capsid degradation. At neutral
pH, the capsid protein band is still detected in the blot, indicating that content-
mixing is dependent on low-pH-induced fusion.
With these fusion assays it will be possible to study full fusion with virus and in
combination with the pyrene lipid-mixing assay, we have the experimental tools to
diﬀerentiate between hemifusion and full fusion. These approaches can be employed
in future studies to dissect the late stages of ﬂavivirus membrane fusion.
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Figure 7.13: Schematic representation of content-mixing assay. Fusion of virus and trypsin-
containing liposomes was induced by acidic pH.
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Figure 7.14: Western Blot analysis of content-mixing assay. Fusion of TBEV with trypsin-
containing liposomes was detected by Western Blot. Digestion of the capsid protein by trypsin at
acidic pH was detected with a C protein directed serum.
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In this work, we were able to gain new insights into the mechanism of ﬂavivirus
membrane fusion and the role of the stem region of E in the fusion process. We
investigated the eﬀect of mutations in the E protein stem and DII on fusion and
fusion-related processes in two diﬀerent experimental systems.
Using the RSP system, we could show, that the early steps of the fusion process
were not aﬀected by mutations at the DII/stem interaction site (coﬂotation data).
However, reduced E protein trimer stabilities of stem mutants revealed that the
stem contributes to the overall stability of the postfusion conformation. The strongly
impaired fusion activity of the L223I mutant RSP in the in vitro fusion assay implied,
that the single mutation in DII crucially aﬀected the late stages of fusion. The trimers
of this mutant RSP were also clearly reduced in thermostability, indicating that these
trimers cannot apply suﬃcient energy to drive the fusion process. By additionally
replacing the interacting stem residue F403 by an isoleucine, the negative eﬀect
could be partially compensated, most likely facilitated by intramolecular interactions
between DII and the stem, which might be important for the correct positioning of
the stem during stem-zippering along the trimer core.
Despite their strong eﬀects on RSP fusion, the same mutations introduced into
the virus still allowed the production of infectious virions, albeit with a reduction in
speciﬁc infectivity compared to WT virus. There are several, not mutually exclusive
explanations for these ﬁndings:
One explanation for the discrepancy between RSP fusion and virus infectivity
might be due to the diﬀerent experimental set up. A cellular system provides diﬀe-
rent environmental factors, which might facilitate virus entry. Fusion usually occurs
from within the early endosome but can also occur later in the endocytic pathway
(77). The pH continually decreases from early endosomes to late endosomes up to
lysosomes. In addition to the high pH variability in living cells, the lipid composition
and thus biophysical properties also diﬀer in the vesicles of the endocytic pathway
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(72). In contrast, the in vitro fusion assay directly analyzes membrane fusion, me-
diated by the E protein, under deﬁned conditions.
Another explanation for the discrepancy in mutant RSP fusion and mutant virus
infectivity could be the diﬀerent particle architecture of RSPs and virions. RSPs
are 30 nm in diameter and thus about two thirds smaller than whole virions (Figure
8.1). Based on their size they have a higher curvature and are covered by 30 E
dimers compared to 90 E dimers on virions (19). The E protein dimers on viral
particles are more densely packed and in sets of three parallel dimer rafts arranged
in a herringbone-like structure (39). The diﬀerence in number and arrangement of E
proteins on the particle surface might be a reason for a stronger impact of mutations
on RSP fusion. The E protein transition into stable trimers provides the energy for
membrane fusion. Due to the dense E protein assembly on the virus surface, more E
proteins are present at the fusion site and can thus contribute to the energy-driven
fusion process. Hence, this special surface architecture of virions might favor the
compensation of deﬁciencies derived from mutations, which destabilized the trimer
through cooperative interactions of multiple E proteins at the fusion site, which is
not possible to the same extent on RSPs.
Figure 8.1: Schematic representations of TBE virion and RSP. (A) Pseudo-atomic structure of a
ﬂavivirus virion. Three E protein dimers are arranged in a raft, indicated by lighter colors. Stars
are labeling DIIIs, which belong to an icosahedral asymmetric unit. (B) Pseudo-atomic structure
of a RSP of ﬂavivirus (adapted from (34)).
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Moreover, the positions of E proteins relative to each other and the particle curva-
ture might be important for possible supramolecular assemblies. It has been hypoth-
esized that ﬁve E protein trimers with their fusion peptides inserted into the target
membrane might act together in a ring formation to induce a nipple-like deformation
in the target membrane, which leads to hemifusion (9). As proposed for the SFV E1
the stem is hypothesized to function as a spacer between DIIs of diﬀerent subunits to
keep them in an open conformation and facilitate lateral interactions between adja-
cent trimers via the fusion peptides (9). If there is a supramolecular cooperation and
the stem functions as spacer, RSPs might be more susceptible to the disruption of
stem/DII contacts than densely packed virions, since the arrangement of E proteins
relative to each other is diﬀerent. A model of supramolecular interaction between
fusion proteins, working together to mediate fusion has also been described for other
viral fusion proteins, for example the inﬂuenza class I fusion protein HA. It has been
shown that inﬂuenza virus fusion requires at least three cooperating HA trimers.
Moreover, it has been observed that the density of the fusion proteins on the surface
of HA expressing cells inﬂuences the kinetics of the fusion process (14, 22).
To resolve the observed discrepancies, we attempted to directly compare mutant
RSPs and virions in the same fusion assay. Unfortunately, the production of pyrene-
labeled viruses resulted in immature forms and could not be used for reliable fusion
assays.
In this work, we have gained important new insights into the ﬂavivirus fusion
mechanism, especially through the use of RSPs as a model system. Unfortunately,
signiﬁcant diﬃculties were encountered when transferring the observations made
with RSPs to the infectious virus system. These problems included diﬀerent eﬀects of
mutations on particle assembly and fusion, respectively infection. The data, obtained
with the two systems were not contradictory, but indicated a stronger eﬀect of speciﬁc
mutations on RSP assembly and fusion, compared to virus. Future investigation will
be necessary to resolve this issue and to obtain a complete picture of the mechanism
of ﬂavivirus membrane fusion.
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